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Abstract
This dissertation focuses on the synthesis of protein-based materials for
biological and environmental applications, via environmentally friendly green chemistry
procedures. For biological applications, fluorescent single protein nanoparticles with
improved thermal stability are designed. A single-layer or double-layer of lipid molecules
are conjugated to the protein surface chemically and/or physically. With lipid molecules
attached, the thermal stability of proteins is improved significantly, and the compositions
and dimensions of generated protein nanoparticles is under precise control. The size
and emission color of these protein nanoparticles can be tuned independently, which is
a unique advantage over quantum dots. From these studies, a universal approach is
established to formulate and construct a 0-dimensional framework that incorporates
protein/enzyme via protein/enzyme surface modification, to enhance the thermal
stability and storage stability. Generated fluorescent single protein nanoparticles are
water-soluble, non-toxic, biocompatible and biodegradable, and suitable for biological
applications such as cell imaging, nucleic acids delivery, and vaccines delivery.
For environmental applications, with the goal of producing solar energy
conversion devices that are cost friendly and sustainable, artificial light antenna systems
and photon upconversion systems using biological soft materials are designed and
evaluated. Self-healing hydrogels are generated by thermal-induced protein-lipid co-
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assembly. With the incorporation of different fluorophores, the energy can be transferred
from the donors to the accepters, to generate desired emissions from the systems. This
is a robust and facile strategy to prepare biocompatible hydrogels composed of protein,
fatty acids, and fluorophores that are mostly biodegradable and biocompatible, which
can be potentially used as solar cell coatings.
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Chapter 1 Introduction
1.1 Protein stabilization
Protein is a promising candidate to prepare biodegradable and biocompatible
materials. However, improved protein thermal stability is a critical requirement for protein
to be applied in practical applications.1 Protein stabilization has been a fundamental
problem and attracted extensive attention. The stability of the protein is principally
determined by intrinsic structure. After stabilization, the stability is dependent on chemical
and physical structure of the carrier, binding position, number of bonds, the
microenvironment that protein molecule is located, etc.2 There are a couple of different
methods reported for protein stabilization and summarized in (Scheme 1.1).
Protein stabilization by the adsorption or chemical bonding on solid supports is one
of the methods.3 For example, nanofibers4 and nanoparticles5 have both been reported
as successful solid supports for protein stabilization. The adsorption of protein on solid
supports is based on weak bonds, including Van der Waal’s forces, electrostatic, or
hydrophobic interactions.6 Chemical bonding between protein and support is another
method for protein stabilization. The chemical bonding connects the functional groups
from enzymes and the support matrix.7
Cross-linkage is another method to improve protein stability. In this method, there
is minimal enzyme leakage as the crosslinking is based on strong chemical bonding
among protein molecules.8 Crosslinking has been proved to significantly improve the
stability of protein towards denaturation by heat or organic solvents. Glutaraldehyde or
carbodiimide are always used as the crosslinkers to prepare crosslinking protein
aggregates.

1

Encapsulation of proteins has also been reported for protein stabilization. Protein
can be encapsulated in metal-organic framework,9 porous materials,10 polymer matrix,11
or liposome.12 By encapsulation, protein is protected by the matrix from denaturation from
physical environmental change and chemical denaturants. Among different encapsulation
matrixes, liposome will be focused in this dissertation. Liposome is a spherical vesical
that has at least one lipid bilayer.13 In biological system, large liposomes are used for cell
membranes, and small liposomes are used to transport biomolecules intracellularly.
Liposome was chosen to encapsulate protein molecules due to its existence in the nature,
biodegradability, and biocompatibility.

2

Scheme 1.1
Protein stabilization from denaturation by pH, temperature, or denaturant. Known
methods include protein stabilization on solid supports, self-immobilization by crosslinked aggregates, and protein encapsulation. Protein encapsulation in liposome
emphasized by the red box is the focus in this dissertation.

3

1.2 Protein hydrogels
Hydrogels are a kind of networks that compositing of hydrophilic polymer chains. 14
The polymers are chosen to be natural or synthetic. Hydrogels have their various
applications including drug delivery,15 wound healing,16 oral delivery,17 tissue
engineering,18 etc. Compared to synthetic polymers, natural polymers omit the polymer
synthesis step, and have their unique advantages as low cost, large abundance,
biocompatibility, and biodegradability. Protein is one of the candidates to prepare natural
protein hydrogels.
Protein is the most common natural polymer. Protein hydrogels are always
prepared with collagen,19 chitosan,20 or gelatin.21 Here we chose bovine serum albumin
(BSA) as the polymer to synthesize hydrogels. BSA is an inexpensive protein and a
waster product from the meat industry and has the advantages as low cost, high
abundance, relative stability, and unique ligand-binding properties. BSA binds various
ligands, including fatty acids,22 hormones,23 metal ions,24 and organic chromophores.25
With these outstanding properties, BSA-based hydrogels provides a special platform for
different applications.
The formation of protein hydrogels can be summarized into two categories, as
chemical crosslinking hydrogel and physical hydrogel (Scheme 1.2). To prepare chemical
crosslinking hydrogel, a crosslinker is always needed to crosslink protein molecules. For
example, carbodiimide,26 glutaraldehyde,27 or “click” chemistry28 can crosslink protein
molecules to form the hydrogel. With a high concentration of protein, a large degree of
crosslinking will induce gelation.

4

Physical-induced protein hydrogels are formed due to physical interactions among
protein molecules rather than chemical bonding. Denatured protein is essential in the
gelation. Denatured proteins have a looser structure with polymer chains exposed on the
surface of the molecules. These exposed chains interact with each other to form protein
3-D network. High temperature,29 high pressure,30 ultrasound,31 or reductant32 can be
used as denaturant to denature protein. Compared to chemical hydrogels, physical
hydrogels have a higher possibility of self-healing, and will be focused in this dissertation.

5

Scheme 1.2
Protein hydrogel synthesis by chemical crosslinking or physical interaction.
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Chapter 2 Artificial Lipoprotein from Protein and Fatty Monoacids
2.1 Abstract
Here we report a novel kind of single protein nanoparticles which has a central
protein core surrounded by two layers of lipid, one layer of which was covalently attached,
and the other layer was physically assembled. The first layer of lipid was attached on the
protein via EDC chemistry, in the presence of excess lipid. After the chemistry reaction
completed, the extra lipid physically attached on modified protein by self-assembly. These
nanoparticles are negatively charged due to the reaction on amine groups and the
addition of carboxyl groups. These particles retained the structure of the protein
embedded at the core of the particle, but the particles have better thermal stability and a
longer shelf time than the constituent protein. These nanoparticles retained 80% of the
protein secondary structure after steam sterilization at 121 oC for 30 min, while native
protein and the physical mixture lost the secondary structure completely. After labeling
with specific fluorescent dyes, these particles emit different colors independent of their
size, which can be potentially applied for cell imaging. In addition, these nanoparticles
have a faster degradation speed than native protein, which has a potential to be used as
drug delivery for fast release. These particles are water-soluble, non-toxic, biocompatible
and biodegradable, and suitable for biological applications such as cell imaging and drug
delivery.
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2.2 Introduction
Proteins and enzymes have a wide range of applications in biological system.
However, one of the most challenges is the thermal stability of these proteins and
enzymes.1 Protein stabilization, especially improving thermal stability of protein, is a
fundamental problem that has been attracting attention. Better protein thermal stability
provides a higher possibility for proteins to retain the intrinsic structure and activity.2 Some
theoretical studies have been done to investigate the parameters that could influence the
thermal stability of protein, including hydrogen bonds, ion pairs, 3 internal packing,4 etc.
However, there were rare studies to evaluate the thermal stabilities under steam
sterilization conditions.
Steam Sterilization is an effective decontamination method that is commonly used
in medical application. Steam sterilization is achieved by exposing products to saturated
steam at high temperatures (121°C to 134°C).5 These extremely high temperatures are
promising candidate conditions to evaluate the success of the strategies used for protein
stabilization. Steam sterilization always caused the loss of activity of protein,6 which is a
serious drawback for applications that require steam sterilization. Protein stabilization
against steam sterilization has been attracting attention.7 However, most of studies only
improve the protein stability to some degree. It is essential to improve proteins’ resistance
to steam sterilization. Enhanced thermal stability is also important for protein storage
stability. Protein-based materials have the most severe problem for transportation and
storage.

It’s critical for protein to retain the structure and activity under different

transportation and storage conditions.8
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Encapsulation of proteins has been reported for protein stabilization. Protein can
be encapsulated in metal-organic framework,9 porous materials,10 polymer matrix,11 or
liposome.12 By encapsulation, protein is protected by the matrix from denaturation from
physical environmental change and chemical denaturants. Among different encapsulation
matrixes, liposome will be focused in this dissertation. Liposome is a spherical vesical
that has at least one lipid bilayer.13 In biological system, large liposomes are used for cell
membranes, and small liposomes are used to transport biomolecules intracellularly.
Liposome was chosen to encapsulate protein molecules due to its existence in the nature,
biodegradability, and biocompatibility.
Recent strategies for protein encapsulation include double emulsification,14
reversal evaporation,15 dry lipid hydration,16 and freeze-thawing.17 However, there are
some disadvantages about reported strategies including low encapsulation efficiency (2527%),18 need of toxic solvents for higher efficiency (65%),19 protein denaturation during
preparation due to the usage of organic solvents and harsh conditions,20 heterogeneous
liposomes formed, limited choice of encapsulated species by spontaneously formed
aqueous core, and multi-step and complicated synthesis.
The thermal stability of proteins can be improved by protein surface modification.
For example, protein-polymer conjugation which combine the biological activities of
proteins with the tailorable structures and properties of synthetic polymers. Proteinpolymer conjugates showed improved thermal stability, resistance to protease and
inhibitor, resistance to thermal stability.21 However, there are still challenges with
synthetic polymers conjugation, such as the control of chemical composition and size,
solubility, and block of active sites.
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Here we reported a modular method to synthesize a novel kind of artificial
lipoprotein (BSA-C10 nanoparticles), by combining suitable lipid molecules with the
protein core to generate a core-shell structure, followed by labeling with specific
fluorescent dyes. The lipid molecules were attached on proteins with well-defined
stoichiometry via carbodiimide chemistry. As the solubility decrease and the
hydrophobicity increased, a second layer of lipid molecules attached on the modified
protein by self-assembly. The attachment does not disrupt the secondary structure of the
protein, which plays an important role in the binding of fluorescent dyes. Synthesized
nanoparticles have significantly improved thermal stability. These nanoparticles retained
80% of the protein secondary structure after steam sterilization at 121 oC for 30 min, while
native protein and the physical mixture lost the secondary structure completely. The
emission color of the BSA-C10 nanoparticles is tunable based on the chromophores
attached to the particles, independently from the size. Compared to quantum dots,
fluorescent dye-labeled protein nanoparticles are advantageous because of easier
preparation, better solubilities, biocompatibility, and biodegradability.
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2.3 Experimental
2.3.1 Materials
Fatty acid free bovine serum albumin (BSA) was purchased from Equitech Bio
(Kerville, TX). 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and succinic acid
were purchased from TCI America (Portland, OR). Sodium phosphate dibasic, decanoic
acid, and ﬂuorescein isothiocyanate (FITC) were purchased from Sigma Aldrich
(Milwaukee,

WI).

5-(and-6)-carboxy-x-rhodamine,

diethylaminocoumarin-3-carboxylic

acid,

succinimidyl

succinimidyl

ester

ester
(DEAC),

(Rox),

7-

and

7-

Methoxycoumarin-3-hydroxy succinimidyl ester (MC) were purchased from Ananspec
(Fremont, CA).
2.3.2 Synthesis of BSA-C10 artificial lipoprotein
140 mM decanoic acid (C10) was dissolved in phosphate buffer (50 mM, pH 8.0)
with 140 mM NaOH. And then 30 mM EDC was dissolved in C10 solution and stirred for
40 minutes at room temperature. 0.1 mM BSA was then added into activated C10 solution
and stirred for 3 hours at room temperature.
2.3.3 Dynamic Light Scattering (DLS)
Hydrodynamic size of BSA and BSA-C10 nanoparticles were monitored by means of
photon correlation spectroscopy with Precision Detectors (Varian Inc.), CoolBatch+ dynamic
light scattering apparatus with 10 × 10 mm2 cuvette, 658 nm excitation laser source with a 90°
geometry. Data collection was done at room temperature, 1 s response, 3 repetitions, and
100 accumulations. BSA and the BSA-C10 nanoparticles were dissolved in 50 mM phosphate
buffer, and the solutions were filtered with 0.22 μm filters (polyvinylidene diﬂuoride, PVDF,
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13 mm, Restek) before the measurements. Precision Ellucidate v 1.1.0.9 and Precision
Deconvolve v 5.5 were used to collect and analyze the data, respectively.
2.3.4 Zeta potential
The surface charge of BSA and BSA-C10 nanoparticles was characterized by zeta
potential. The samples were prepared by mixing 0.1 mM protein with 1 mM KCl. The zeta
potential was got from ZetaPlus Zeta Potential Analyzer from Brookhaven instruments
corporation. Each measurement is the average of three accumulations, with the average
and the standard deviation calculated.
2.3.5 Transmission electron microscopy (TEM)
BSA-C10 nanoparticles were diluted with distilled water to 20 µg/mL and 12 µL of
sample was drop-cast onto a TEM grid (TED PELLA, Inc., CA:Ultrathin carbon film
supported by a lacey carbon film on a 400 mesh copper grid. Product No. 01824).
Whatman 1 filter paper was used to dab off extra solution after 3 minutes. The grid was
left to dry for 2 minutes and then 10 µL of 1% ammonium molybdate stain (ammonium
molybdate dissolved in distilled water and pH adjusted to 7 using concentrated NaOH,
filtered through 0.2 µm filter before use) was dropcast onto the sample for 15 seconds
before removing excess stain by dabbing with filter paper. The sample was then left to
dry overnight before being taken for imaging. A FEI Tecnai T12 S/TEM was used for
imaging with an accelerating voltage of 120 kV.
2.3.6 Agarose gel electrophoresis
0.5% agarose gel was prepared. 125 mg agarose was dissolved in 25 mL trisacetate buffer (40 mM, pH 7.0) by microwaving for 30 seconds. The agarose solution was
then poured and stand for 30 minutes at room temperature. Samples were prepared by
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mixing 10 μg protein with 10 μL of agarose loading buffer (50% v/v glycerol solution
containing 0.01% m/v bromophenol blue). The agarose gel was run at 100 mV for 35
minutes with Gibco BRL Model 200 power supplier. After running, the agarose gel was
stained with 20% v/v acetic acid solution containing 0.003% m/v brilliant blue R-250, and
destained with 10% v/v acetic acid solution.
2.3.7 Polyacrylamide gel electrophoresis (SDS-PAGE)
The gel contains separating gel (7.5%) on the bottom and stacking gel on the top.
The samples were prepared by mixing 10 μg protein with 10 μL loading buffer (2% SDS,
10% BME) and heated in water bath for 5 minutes. The gel was run at 200 mV for 1 hour
with V in Bio-Rad Mini Protean Electrophoresis apparatus until the dye front was 1 cm
from the bottom of gel plate. After running, the gel was stained with stain I (10% v/v acetic
acid, 10% v/v isopropanol, 0.003% m/v brilliant blue R-250) and stain II (20% v/v acetic
acid, 0.003% m/v brilliant blue R-250), and destained with 10% v/v acetic acid solution.
2.3.8 Circular Dichroism (CD)
The retention of the secondary structure was tested by circular dichroism (CD). CD
spectra were got from Jasco J-710 spectropolarimeter. There were around 0.3 μM protein
dissolved in 50 mM phosphate buffer (pH 8.0) in the samples used for measurements.
Spectra were obtained using a 0.05 cm path length quartz cuvette from 260 nm to 190
nm. The sensitivity was set as100 mdeg and the data pitch as 0.5 nm, with continuous
scanning mode, 50 nm min-1 scanning speed, 1 s response, 1.0 nm bandwidth, and three
accumulations. The baseline was measured with 50 mM phosphate buffer (pH 8.0) and
subtracted from each spectrum.
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2.3.9 Proteolytic digestion by trypsin and chymotrypsin
BSA, BSA/C10, or BSA-C10 was dissolved in 50 mM tris-HCl buffer (pH 8.6). The
concentration of the protein was kept at 1 mg/mL (15 µM). The molar ratio between
protease and protein was kept at 20:1. After mixing protein with protease (trypsin or
chymotrypsin), the mixture solution was incubated in 37 oC water bath for desired time
lengths, 1, 3, 5 hours, or overnight. The reaction was quenched by storing the solution in
the freezer. The samples were thawed right before it was ready for SDS-PAGE.
2.3.10 Thermal stability studies
The thermal stabilities of BSA-C10 nanoparticles, BSA, and the physical mixture
of BSA and C10 were tested by 80 oC water bath and steam sterilization. For the studies
at 80 oC, the solutions of different protein samples (0.2 mM in 50 mM phosphate buffer,
pH 8.0) were heated in an 80 oC water bath for 20 minutes, and then cooled at room
temperature on the bench top for 20 minutes. A heating and cooling process was called
a cycle, and the studies were done for a total of five cycles. For the studies of thermal
stability by steam sterilization, the solutions of different protein samples (0.2 mM in 50
mM phosphate buffer, pH 8.0) were steam sterilized in BioClave from BenchMark
Scientific (Melrose, MA) at 121 °C (with pressure around 17 psi) holding for 30 minutes.
Samples were then cooled down to room temperature on the bench top overnight. The
samples were centrifuged to remove precipitate, if any, before CD measurements.
2.3.11 Preparation of solid BSA-C10 sample
The solid BSA-C10 sample was prepared by removing the physically attached C10
layer. The pH of original BSA-C10 nanoparticle solution was adjusted to 2 by adding
phosphoric acid. And then the solution was centrifuged at 10k rpm for 15 minutes. The
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supernatant was removed carefully after centrifugation. The precipitate was washed with
toluene three times to remove any unattached decanoic acid and pH 2.0 aqueous solution
to remove any water-soluble byproducts. The solid sample was then dried under vacuum
overnight before any characterization.
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2.4 Results and discussion
2.4.1 Synthesis of BSA-C10 nanoparticles
BSA-C10 nanoparticles were synthesized by covalently linking the carboxylic acid
groups from fatty acid to the amine groups on bovine serum albumin (BSA) using 1-ethyl3-(3-dimethylaminopropyl) carbodiimide (EDC) as the crosslinker. Excess decanoic acid
presented in the solution, to physically attach onto the modified protein later (Scheme
2.1). Briefly, dicarboxylic acids were mixed with EDC with a 14:3 stoichiometry to activate
part of the fatty acid. Then the activated dicarboxylic acids reacted with BSA, resulting in
the formation of amide bonds between carboxylic groups and amine groups. Because of
the attachment of the carbon chains, the solubility of the modified protein decreased. The
excess decanoic physically attached on the modified protein to form water-soluble BSAC10 nanoparticles. After the synthesis, four different active fluorescent dyes were used
to label the BSA-C10 nanoparticles, to be used for potential cell imaging applications,
Rox, TRITC, DEAC, and MC. The structures and full names are shown in Scheme 2.2.
Synthesized fluorescent nanoparticles were purified by adjusting the solution pH to 2.0
with phosphoric acid to precipitate modified protein. After centrifugation, the precipitate
was washed with DMF, toluene, and pH 2.0 aqueous solution, to remove unreacted dyes,
excess decanoic acid, and any water-soluble byproducts. The precipitate was then dried
under vacuum overnight. Fluorescent protein nanoparticle solution was prepared by
dissolving dried solid with 50 mM decanoic acid solution.
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Scheme 2.1
The synthesis of BSA-C10 covalent conjugates. The first layer of C10 is acid is chemically
linked to BSA by EDC chemistry, the second layer of C10 is physically attached via selfassembly.

Scheme 2.2
Structures of reactive dyes used to label BSA-C10 nanoparticles.

19

The stoichiometry among decanoic acid acid, EDC, and BSA was optimized from
a series of reaction conditions, and the formation of the products was monitored by
agarose gel electrophoresis. First, the concentrations of BSA and decanoic acid were
kept constant as 0.1 mM and 140 mM respectively, and the concentration of EDC was
varied. Eight different concentrations of EDC were tested (Table 2.1), and the agarose
electrophoresis was used to evaluate the products (Figure 2.1). The agarose gel showed
that, with increasing concentration of EDC, the synthesized products moved further to the
positive electrode. When the concentration of EDC was 30 mM, there was no unmodified
BSA can be detected from the agarose gel. The synthesized nanoparticles showed a
narrow band on the agarose gel, that is more negatively charged than unmodified BSA.
The concentration of decanoic acid was then optimized by keeping the
concentrations of BSA and EDC constant at 0.1 and 30 mM respectively and varying the
concentration of decanoic acid as 0, 40, 70, 100, and 140 mM (Table 2.2). the agarose
gel electrophoresis was used to evaluate the products (Figure 2.2). With increasing
concentration of decanoic acid, the band on the gel becomes narrower, which means the
size and charge are more uniform. With excess decanoic acid, the solubility of modified
protein increased.
According to the optimization experiments results, 0.1 mM BSA, 30 mM EDC, and
140 mM C10 was used as the optimized conversions to synthesize BSA-C10
nanoparticles. With these concentrations, active amine groups on BSA reacted
completely without cross-linking among BSA molecules. The required concentration of
free decanoic acid was studied and discussed below. Formed nanoparticles (BSA-C10)
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are water-soluble, and the sizes, charges, structures, and stabilities were studied as
described below.
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Table 2.1
Different reaction conditions used to optimize the concentration of EDC. The
concentrations of BSA and decanoic acid were kept constant as 0.1 mM and 140 mM
respectively, and the concentration of EDC was varied as 0, 0.1, 1, 5, 10, 20, and 30 mM.
Unmodified BSA was used as the control.

Figure 2.1
Agarose gel electrophoresis of the products from different reaction conditions described
above. The agarose gel was run with 0.5% agarose and 40 mM tris-acetate buffer (pH
7.0), at 100 V for 30 minutes.
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Table 2.2
Different reaction conditions used to optimize the concentration of decanoic acid. The
concentrations of BSA and EDC were kept constant as 0.1 mM and 30 mM respectively,
and the concentration of decanoic acid was varied as 0, 40, 70, 100, and 140 mM.
Unmodified BSA was used as the control.

Figure 2.2
Agarose gel electrophoresis of the products from different reaction conditions described
above. The agarose gel was run with 0.5% agarose and 40 mM tris-acetate buffer (pH
7.0), at 100 V for 30 minutes.
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2.4.2 Characterizations of BSA-C10 nanoparticles
The hydrodynamic radius of particles was determined from dynamic light scattering
(DLS, Figure 2.3a). DLS data shows that, after the synthesis, a single peat at 11 nm, with
a sharp size distribution. The size is slightly larger than BSA. The high intensity
percentage means the particles are uniform. Compared to the size of BSA molecules
which have a size at 7 nm, BSA-C10 nanoparticles are bigger, but smaller than the
diameter of two BSA molecules, demonstrating the formation of single protein
nanoparticles. The conjugation of decanoic acid increased the size by 4 nm in diameter
dimension.
The surface charge of particles was studies by zeta potential analyzer (Figure
2.3b). The zeta potential of BSA-C10 nanoparticles is -35.53±2.76 mV, which is smaller
than the zeta potential of BSA (-4.43±1.9 mV). . The EDC reaction happened on the amine
groups of BSA, and there were excess decanoic acid physically binding to the modified
BSA particles. BSA-C10 has more negative charge on the surface than BSA due to the
decrease in the amount of amine groups as well as the addition of the carboxy groups.

24

Figure 2.3
(a) DLS data of BSA (blue curve) and BSA-C10 nanoparticles. (b) Zeta potential of BSA
(blue) and BSA-C10 nanoparticles (red).
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2.4.3 Gel electrophoresis
The net charge of unmodified BSA, the physical mixture BSA/C10, and BSA-C10
nanoparticles was also studied by agarose gel electrophoresis. In the agarose gel (Figure
2.4a), BSA-C10 nanoparticles moved further toward the positive electrode than
unmodified BSA, while the physical mixture BSA/C10 was at a similar position with BSA.
As the DLS showed above, the size of BSA-C10 nanoparticles was similar to that of
unmodified BSA, but slightly bigger. As the pore size of 0.5% agarose gel that used in
this study was determined as hundreds of nanometers, compared to which the size of
BSA and BSA-C10 nanoparticles are on the same scale and cannot be separated on the
agarose gel based on the size. Because of the reaction happed on the positively charged
amine groups and the addition of negatively charged carboxylic acid groups, the charge
of BSA-C10 nanoparticles is expected to be more negative than unmodified protein.
Therefore, the separation of BSA and BSA-C10 nanoparticles on the agarose gel is
mainly because of the change of net charge of protein, rather than the change of size.
This observation is also consistent with zeta potential discussed above.
The physical mixture of BSA and decanoic acid was used as a control. The
physical mixture was prepared by mixing BSA and decanoic acid with the same
concentrations used in the chemical conjugates, but without EDC added. The interaction
between BSA and diacids in these physical mixtures is physical binding instead of
chemical linking. On the agarose gel, the physical mixtures had similar mobility with pure
BSA, indicating that the physical interaction between BSA and diacids doesn’t change the
size or the charge of the protein. The change on the mobility of the chemical conjugates
is further confirmed as a result of the chemical reactions happened on the protein.
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SDS-PAGE was used to test the formation of the BSA-C10 nanoparticles
according to the molecular weight of samples (Figure 2.4b). On the SDS-PAGE, there
was no band showed at high molecular weight position, which indicates that there was no
crosslinking among protein molecules and confirms the formation of single protein
nanoparticles. The band position of BSA-C10 is similar to unmodified BSA, but smear,
because after modification with DDDA, BSA molecules was covered with a layer of carbon
chains and physically attached decanoic molecules on the surface. When BSA-C10
nanoparticles were dissolved in SDS micelles, SDS micelles can’t block BSA-C10
nanoparticles completely, and the carboxylic acid groups are still exposed to the solvent.
The charge of SDS/BSA is just the strong negative charge from SDS micelles, while the
charge of SDS/BSA-C10 is an addition of the charge SDS micelles and the charge of
carboxylic groups on BSA-C10 nanoparticles.
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Figure 2.4
(a) Agarose gel electrophoresis of unmodified BSA (lane 1), physical mixture BSA/C10
(lane 2), and BSA-C10 nanoparticles (lane 3). The agarose gel was run with 0.75 µg of
protein in each well. The gel was run with 40 mM tris-acetate buffer (pH 7.0), at 100 V for
30 minutes. (b) SDS-PAGE of unmodified BSA (lane 2), physical mixture BSA/C10 (lane
3), and BSA-C10 nanoparticles (lane 4). A standard protein marker (lane 1) was used to
estimate the molecular weights of the samples.
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2.4.4 Structure retention of BSA-C10 nanoparticles
The structure retention of BSA before and after the attachment of fatty acids was
tested with circular dichroism (CD) in the UV region (260 nm-190 nm) (Figure 2.5). The
CD spectra were normalized with concentrations determined by UV-Vis absorbance
spectroscopy, using the know extinction coefficient of BSA, 43824 M-1 cm-1. The physical
mixture BSA/C10 was used as the control. The shape and peak intensity of CD spectrum
of BSA-C10 nanoparticles are nearly identical to those of BSA. The ratio between the
intensities at 222 nm and 208 nm didn’t change obviously either. The peak intensity at
222 nm of each samples was compared to unmodified BSA to determine the extent
structure retention, which is about 100%. Based on these, we concluded that the protein
secondary structure was not significantly affected by the attachment of diacids via EDC
chemistry.
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Figure 2.5
UV CD of unmodified BSA (black curve), the physical mixture BSA/C10 (blue curve), and
BSA-C10 nanoparticles (red curve) in 50 mM phosphate buffer (pH 8.0). Baseline is
shown as the gray line and was subtracted from each spectrum.
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2.4.5 Fourier-transform infrared spectroscopy (FTIR)
The solid BSA-C10 sample was prepared as described in the experimental section
(Scheme 2.3). Briefly, the pH of as prepared BSA-C10 nanoparticles solution was
adjusted to 2.0 by adding phosphoric acid. As decanoic acid is not soluble in pH 2.0
aqueous solution, the physically attached decanoic acid precipitated. Due to the
precipitation and loss of the physically attached decanoic acid, BSA-C10 also precipitated
dues to the exposure of carbon chains to the aqueous environment. After this step, the
precipitate only contained free decanoic acid, and BSA-C10 without physically attached
decanoic acid. The precipitate was then washed with toluene to remove free decanoic
acid, and then pH 2.0 solution to remove any water-soluble byproducts. The BSA-C10
solid sample prepared this way only contained the chemical conjugate of BSA-C10,
without the second layer of decanoic acid.
Fourier transform infrared spectroscopy (FTIR) was used to study the change of
chemical bonds of BSA-C10 solid sample (Figure 2.6). The peak at 1530 cm-1 is assigned
as amide II band, which derives mainly from N-H bending. The peak at 1645 cm-1 is
assigned as amide I band, which derives mainly from C=O stretching. After reaction, the
ratio of peak intensity between amide I and amide II increased. As the sample use for FTIR study was the BSA-C10 solid sample without any free decanoic acid presenting, the
increase of C=O peak intensity is only due to the chemical conjugation of decanoic acid
by EDC chemistry.
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Scheme 2.3
The preparation of BSA-C10 solid sample. Phosphoric acid was added into as prepared
BSA-C10 nanoparticles solution to adjust the pH to 2.0. The precipitate containing free
decanoic acid and BSA-C10 conjugate was separated by centrifugation. The precipitate
was washed with toluene and pH 2.0 solution to remove free decanoic acid and any watersoluble byproducts. The precipitate left is the water insoluble BSA-C10 solid without the
physically attached decanoic acid. BSA-C10 solid sample was fried before any studies.
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Figure 2.6
FT-IR spectra of BSA solid (blue curve) and BSA-C10 solid sample (red curve). BSA-C10
solid sample didn’t contain any physically attached decanoic acid and was prepared as
described above.
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2.4.6 Solubility of BSA-C10 solid in decanoic acid solution
As the BSA-C10 solid is not water-soluble and needs a second layer of free
decanoic acid to physically attach, therefore, to be soluble in water, the solid BSA-C10
sample can be dissolved back in decanoic acid solution. To test our hypothesis, BSAC10 solid sample was prepared as described above. The same mass of BSA-C10 solid
sample was then added into the same volume of different concentrations of decanoic acid
solution. The mixtures were then incubated at room temperature for 10 minutes or 24
hours, followed by centrifuged at 10k rpm for 15 minutes. The photographs were taken
after centrifugation (Figure 2.7), and the supernatants were used to run the agarose gel
to determine the amount of protein presented (Figure 2.8).
BSA-C10 solid sample was dissolved in 50 mM and 100 mM decanoic acid
solutions immediately after mixing. There was no visible precipitate after centrifugation.
When BSA-C10 solid sample was mixed with 20 mM decanoic acid solution, the solid
was dissolved after 24 hours. When the concentration of decanoic acid was lower than
20 mM, there was still precipitate after 24 hours. The amount and the charge of dissolved
protein were determined by agarose gel electrophoresis.
The agarose gel shows that with higher concentration of decanoic acid solution
mixed with BSA-C10 solid, the darkness of the protein band increased. This is consistent
with the observations described above, that with more free decanoic acid presenting,
there was more BSA-C10 solid can be dissolved. Furthermore, with increasing
concertation for free decanoic acid presenting in the solution, the charge of formed
nanoparticles was more negative, indicating that more decanoic molecules have been
physically attached to the modified BSA. These observations confirm our hypothesis that
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the second layer of decanoic acid is physically attached to the chemically modified BSA
and increases the solubility of BSA-C10 nanoparticles.
To study the hydrodynamic sizes of formed nanoparticles by mixing BSA-C10 solid
with decanoic acid solution, DLS was tested on BSA-C10 solid mixed with 20, 50, and
100 mM decanoic acid solutions (Figure 2.9). With 20 mM decanoic acid presenting in
the solution, formed nanoparticles had the hydrodynamic size as 38 nm with a smaller
portion at 10 nm. With 50 and 100 mM decanoic acid, formed nanoparticles had a larger
portion at 10 nm, and the percentage at larger size decreased. With more decanoic acid,
the BSA-C10 solid can be blocked and separated better with free decanoic acid
presenting in the solution. Interestingly, the critical micelle concentration (CMC) of
decanoic acid at room temperature is around 50 mM. When the concentration of free
decanoic acid is higher than the CMC, C10 micelles form in the solution. When solid BSAC10 is added into the micelles solution, the micelles incorporate BSA-C10 by hydrophobic
interaction to form water-soluble BSA-C10 nanoparticles.
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Figure 2.7
Photographs of BSA-C10 solid sample mixed with different concentrations of decanoic
acid solutions after (a) 10 minutes and (b) 24 hours. From the left to right, the
concentrations of decanoic acid solutions are: 0 mM (pH 7.8), 0.5 mM (pH 7.6), 1 mM (pH
7.6), 5 mM (pH 7.6), 10 mM (pH 7.6), 20 mM (pH 7.7), 50 mM (pH 7.9) and 100 mM (pH
8.3). The photographs were taken after centrifugation of solutions at 10k rpm for 30
minutes.

Figure 2.8
The agarose gel electrophoresis of the supernatant samples after BSA-C10 solid sample
mixed with different concentrations of decanoic acid solutions. Lane 1: BSA, lanes 2-9:
supernatant of BSA-C10 solid sample mixed with different concentrations of decanoic
acid solution (0 mM, 0.5 mM, 1 mM, 5 mM, 10 mM, 20 mM, 50 mM, 100 mM).
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Figure 2.9
DLS of BSA-C10 solid dissolved in (a) 20, (b) 50, and (c) 100 mM decanoic acid solutions.
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2.4.7 Structure retention at high temperature
The addition of the double-layer lipid shell on the protein surface was expected to
lower the conformational entropy of the denatured state and thereby increase thermal
stability of the bioconjugate. The thermal denaturation curves were obtained by
monitoring the secondary structure of the protein as a function of temperature for
unmodified BSA, the physical mixture BSA/C10, and BSA-C10 nanoparticles (Figure
2.10 a-c). The CD intensity at 222 nm was used to evaluate the extent of secondary
structure retention (Figure 2.10 d-f). For unmodified BSA, the secondary structure started
to lose significantly when the temperature was higher than 55 oC. When the temperature
was around 90 oC, BSA completely lost the secondary structure. For the physical mixture
BSA/C10, the addition of decanoic acid improved the thermal stability to some degree.
The secondary structure of protein didn’t change significantly until the temperature was
higher than 70 oC. However, when the temperature reached 90 oC, the protein lost the
secondary structure completely as well. On the contrary, BSA-C10 sill retained more than
more than 50 % of the secondary structure when the temperature was as high as 90 oC.
The retention of the secondary structure showed a rough linear relationship with the
temperature (Figure 2.11). Thus, covalent conjugation and physical attachment of
decanoic acid improved the temperature of denaturation of BSA, as expected, and
improved the resistance of protein to high temperature denaturation.
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Figure 2.10
CD spectra of (a) BSA, (b) BSA/C10, and (c) BSA-C10 at different temperature from 24
oC

to 90 oC in phosphate buffer. The blank was measured with phosphate buffer (50 mM,

pH 8.0), shown as black dash line, and subtracted from each spectrum.
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Figure 2.11
The CD intensity at 222 nm plotted versus the temperature for unmodified BSA (black
curve), the physical mixture BSA/C10 (blue curve), and BSA-C10 nanoparticles (red
curve).
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2.4.8 Thermal stability studies
The thermal stability and reversibility from thermal denaturation was tested by
heating and cooling the samples following by taking CD spectra to evaluate the structure
retention. Unmodified BSA, the physical mixture BSA/C10, and BSA-C10 nanoparticles
were tested. each sample was heated in 80oC oven for 20 minutes and then cooled at
room temperature for 20 minutes. This heating and cooling cycle was repeated 5 times.
The samples were centrifuges before any spectra were taken, to remove any precipitate.
The CD spectra were used to study the secondary structure of protein (Figure 2.12), and
the intensity at 222 nm was used to evaluate the structure retention and recovery (Table
2.3). After 1 cycle of heating and cooling, unmodified BSA, the physical mixture BSA/C10,
and BSA-C10 nanoparticles didn’t show obvious differences about the secondary
structure retention, and remained 94.3%, 96.1%, and 96.1% structure, respectively. The
secondary structure of unmodified BSA decreased to 80% after three cycles, and 43.9%
after 5 cycles. The physical mixture BSA/C10 lost more than 30% secondary structure
after five cycles. BSA-C10 nanoparticles showed better reversibility from the thermal
denaturation than both BSA and BSA/C10. After five cycles of heating and cooling as
described above, BSA-C10 still remained nearly 100% of the secondary structure. The
CD spectra of BSA-C10 after each cycle of heating and cooling look nearly identical. This
demonstrates that the chemical conjugation and physical attachment of the double-layer
lipid shell not only improves the resistance towards high temperature, but also the
reversibility towards thermal denaturation.
After the confirmation of the improvement of the thermal stability of protein by the
double-layer lipid shell, we tested a harsher environment of thermal denaturation by
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steam sterilization. Unmodified BSA, the physical mixture BSA/C10, and BSA-C10
nanoparticles solutions were steam sterilization at 121 oC with 17 psi and held for 30
minutes. The samples were then cooled at room temperature overnight. The heating and
cooling process was called one cycle, and the studies were done in a total of eight cycles.
Centrifugation was performed to remove any precipitate before CD measurements
(Figure 2.13). The CD spectra showed that after one cycle of steam sterilization and
cooling, for both unmodified BSA and the physical mixture BSA/C10, the secondary
structure was completely lost and turned to random coil. For BSA-C10 nanoparticles,
about 40% of the secondary structure was retained after nine cycles of steam sterilization
and cooling.
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Figure 2.12
CD spectra of (a) BSA, (b), BSA/C10, and (c) BSA-C10 after 5 cycles of heating and
cooling process. All the samples were heated at 80 oC for 20 minutes and cooled at room
temperature for 20 minutes in each cycle. The samples were centrifuged before
measurements. The studies were carried out in 50 mM phosphate buffer (pH 8.0).

Table 2.3
Summary of secondary structure retention of BSA, BSA/C10, and BSA-C10 after heating
and cooling cycles. The CD intensity at 222 nm was used to calculate the structure
retention percentage.
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Figure 2.13
CD spectra of (a) BSA, (b), BSA/C10, and (c) BSA-C10 after 8 cycles of steam sterilization
and cooling process. All the samples were steam sterilized at 121 oC holding for 30
minutes and cooled at room temperature overnight in each cycle. The samples were
centrifuged before measurements. The studies were carried out in 50 mM phosphate
buffer (pH 8.0).
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2.4.9 Biodegradability by proteolysis
The biodegradability of BSA, the physical mixture BSA/C10, and BSA-C10
nanoparticles was tested by incubating the protein samples with two different proteases,
trypsin and chymotrypsin. The studies were carried out in 50 mM tris-HCl buffer (pH 8.6).
The protease was mixed with protein with a molar ratio of 1:20. The reaction mixtures
were incubated in 37 oC water bath for different time lengths. The efficiency of the
proteolysis was evaluated by SDS-PAGE (Figure 2.14). The chemical conjugate showed
a faster degradation rate than unmodified BSA, while the physical mixture showed a
slower degradation rate. Saturated fatty acid has been reported to inhibit trypsin, which
explains the slower rate of proteolysis for the physical mixture, as the fatty acid in the
sample was rarely or loosely bound. The free fatty acid can bind to and inhibit trypsin.
However, for the chemical conjugate, the free fatty acid layer is tightly bound in the particle.
Unlike free fatty acid in the physical mixture, the fatty acid that physically attached to the
particle doesn’t bind to trypsin or inhibit trypsin furthermore.
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Figure 2.14
SDS-PAGE of proteolysis products by hydrolyze BSA, BSA/C10, and BSA-C10 with
trypsin. The samples were frozen after 1 hour and 3 hours to quench the reaction.
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2.4.10 Synthesis of fluorescent artificial lipoprotein
As a potential application, we labeled BSA-C10 nanoparticles with reactive
fluorescent dyes to give particles multiple different colors. The color is tunable based on
the fluorescent dye used, and the color tunability is independent of the size of the BSAC10 nanoparticles. Four different fluorescent dyes were used, as Rox, TRITC, DEAC,
and MC. After purification, the solid samples were then dissolved with 50 mM decanoic
acid solution.
The charge and the size were studied by agarose gel electrophoresis. The agarose
gel was run at pH 7.0 to separate free dyes and labeled BSA-C10 nanoaprticles. The
agarose gel was imaged under the UV light to reveal the positions of labeled BSA-C10
nanoparticles and free dyes (Figure 2.15). For example, in the Rox labeled BSA-C10
nanoparticles (Figure 2.15, Lane 4), only a single band was shown and there was no
band corresponding to the unreacted Rox (Lane 3), which confirmed the purity of Rox
labeled BSA-C10 nanoparticles. The same agarose gel was then stained with Coomassie
Blue and imaged under the ambient light, to reveal the position of the protein. It shows
that the position of the unlabeled BSA-C10 nanoparticles and Rox labeled BSA-C10
nanoaprticles are about the same, which demonstrates that the labeling of fluorescent
dyes doesn’t change either the size or the charge.
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Figure 2.15
Agarose gel electrophoresis of BSA-C10 nanoparticles labeled with Rox, DEAC, TRITC,
and MC. Unmodified BSA, unlabeled BSA-C10 nanoparticles, and free dyes were used
for comparison. The gels were observed under 365 nm UV light, and then stained and
destained as described above to observe the protein location. The gels were run with pH
7.0 tris-acetate buffer.
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Figure 2.16
Absorbance and emission spectra of free dyes used to label BSA-C10 nanoparticles in
aqueous solution and dyes labeled BSA-C10 nanoparticles.
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2.5 Conclusions
Here, we report a robust and efficient protocol to prepare water-soluble single
protein artificial lipoprotein that are synthesized efficiently by coupling the COOH groups
decanoic acid with the amine functional groups on bovine serum albumin by carbodiimide
coupling. Liposome is formed around each protein molecules with precisely chemical
control. After the first layer of lipid chemically attached on each protein molecule
chemically, as the solubility decrease and the hydrophobicity increased, a second layer
of lipid molecules attached on the modified protein by self-assembly. Formed
nanoparticles showed faster digestion rate by proteolysis. The thermal stability of BSAC10 nanoparticles was significant improved with the double-layer lipid shell. Formed
liposome is uniform, and the protein encapsulated is not limited to the liposome size. it’s
a modular method to prepare protein encapsulation in liposome, with 100% encapsulation
efficiency. The synthesis is under mild reaction condition, with no denaturation of protein
during preparation.

50

2.6 References
1
2
3
4
5

6

7

8

9

10

11

12

13

14
15

16
17

Haki, G. D.; Rakshit, S. K. Developments in Industrially Important Thermostable
Enzymes: A Review. Bioresour. Technol. 2003, 89 (1), 17–34.
Argos, P.; Rossmann, M. G.; Grau, U. M.; Zuber, H.; Frank, G.; Tratschin, J. D.
Thermal Stability and Protein Structure. Biochemistry 1979, 18 (25), 5698–5703.
Vogt, G.; Woell, S.; Argos, P. Protein Thermal Stability, Hydrogen Bonds, and Ion
Pairs. J. Mol. Biol. 1997, 269 (4), 631–643.
Vogt, G.; Argos, P. Protein Thermal Stability: Hydrogen Bonds or Internal Packing?
Fold. Des. 1997, 2 (4), 40–46.
Baier, R. E.; Meyer, A. E.; Akers, C. K.; Natiella, J. R.; Meenaghan, M.; Carter, J.
M. Degradative Effects of Conventional Steam Sterilization on Biomaterial Surfaces.
Biomaterials 1982, 3 (4), 241–245.
Thilakarathne, V.; Briand, V. A.; Zhou, Y.; Kasi, R. M.; Kumar, C. V. Protein Polymer
Conjugates: Improving the Stability of Hemoglobin with Poly(Acrylic Acid).
Langmuir 2011, 27 (12), 7663–7671.
Mudhivarthi, V. K.; Cole, K. S.; Novak, M. J.; Kipphut, W.; Deshapriya, I. K.; Zhou,
Y.; Kasi, R. M.; Kumar, C. V. Ultra-Stable Hemoglobin-Poly(Acrylic Acid)
Conjugates. J. Mater. Chem. 2012, 22 (38), 20423–20433.
Cleland, J. L.; Lam, X.; Kendrick, B.; Yang, J.; Yang, T. H.; Overcashier, D.; Brooks,
D.; Hsu, C.; Carpenter, J. F. A Specific Molar Ratio of Stabilizer to Protein Is
Required for Storage Stability of a Lyophilized Monoclonal Antibody. J. Pharm. Sci.
2001, 90 (3), 310–321.
Lyu, F.; Zhang, Y.; Zare, R. N.; Ge, J.; Liu, Z. One-Pot Synthesis of ProteinEmbedded Metal-Organic Frameworks with Enhanced Biological Activities. Nano
Lett. 2014, 14 (10), 5761–5765.
Volodkin, D. V.; Larionova, N. I.; Sukhorukov, G. B. Protein Encapsulation via
Porous CaCO3 Microparticles Templating. Biomacromolecules 2004, 5 (5), 1962–
1972.
Howes, P.; Green, M.; Levitt, J.; Suhling, K.; Hughes, M. Phospholipid
Encapsulated Semiconducting Polymer Nanoparticles : Their Use in Cell Imaging
and Protein Attachment. J. Am. Chem. Soc. 2010, No. 14, 3989–3996.
Colletier, J. P.; Chaize, B.; Winterhalter, M.; Fournier, D. Protein Encapsulation in
Liposomes: Efficiency Depends on Interactions between Protein and Phospholipid
Bilayer. BMC Biotechnol. 2002, 2, 1–8.
Cevc, G. Rational Design of New Product Candidates: The next Generation of
Highly Deformable Bilayer Vesicles for Noninvasive, Targeted Therapy. J. Control.
Release 2012, 160 (2), 135–146.
Je Lee, S.; Rosenberg, M. Whey Protein-Based Microcapsules Prepared by Double
Emulsification and Heat Gelation. LWT - Food Sci. Technol. 2000, 33 (2), 80–88.
Rigaud, J. L.; Bluzat, A.; Buschlen, S. Incorporation of Bacteriorhodopsin into Large
Unilamellar Liposomes by Reverse Phase Evaporation. Biochem. Biophys. Res.
COMAMJNlCATlONS 1983, 111 (2), 373–382.
Tsai, F. C.; Stuhrmann, B.; Koenderink, G. H. Encapsulation of Active Cytoskeletal
Protein Networks in Cell-Sized Liposomes. Langmuir 2011, 27 (16), 10061–10071.
Crowe, L. M.; Womersley, C.; Crowe, J. H.; Reid, D.; Appel, L.; Rudolph, A.
51

18

19

20

21

Prevention of Fusion and Leakage in Freeze-Dried Liposomes by Carbohydrates.
Biochim. Biophys. Acta 1986, 861, 131–140.
Cortesi, R.; Esposito, E.; Gambarin, S.; Telloli, P.; Menegatti, E.; Nastruzzi, C.
Preparation of Liposomes by Reverse-Phase Evaporation Using Alternative
Organic Solvents. J. Microencapsul. 1999, 16 (2), 251–256.
Xu, X.; Costa, A.; Burgess, D. J. Protein Encapsulation in Unilamellar Liposomes:
High Encapsulation Efficiency and a Novel Technique to Assess Lipid-Protein
Interaction. Pharm. Res. 2012, 29 (7), 1919–1931.
Andrade, C. A. S.; Correia, M. T. S.; Coelho, L. C. B. B.; Nascimento, S. C.; SantosMagalhães, N. S. Antitumor Activity of Cratylia Mollis Lectin Encapsulated into
Liposomes. Int. J. Pharm. 2004, 278 (2), 435–445.
Riccardi, C. M.; Cole, K. S.; Benson, K. R.; Ward, J. R.; Bassett, K. M.; Zhang, Y.;
Zore, O. V.; Stromer, B.; Kasi, R. M.; Kumar, C. V. Toward “Stable-on-the-Table”
Enzymes: Improving Key Properties of Catalase by Covalent Conjugation with
Poly(Acrylic Acid). Bioconjug. Chem. 2014, 25 (8), 1501–1510.

52

Chapter 3 Single Protein Nanoparticles from Protein and Fatty Diacids
3.1 Abstract
In this study, a novel kind of single protein nanoparticles (FluoDot) with tunable
sizes and improved thermal stabilities is reported here. FluoDo nanoparticles are
composed of one central protein core surrounded by a covalently linked lipid layer. The
lipid layer is permeable thus the protein is approachable. The size of FluoDot
nanoparticles is tunable at 2.5 Å resolution with a sharp size distribution, by changing the
thickness of the lipid layer. FluoDot nanoparticles are more negatively charged compared
to unmodified protein, independent of the size of FluoDot nanoparticles. After modification,
FluoDot nanoparticles fully retained the structure of the protein embedded at the core of
the particle but have a better thermal stability and a longer shelf time than constituent
protein. Additionally, the thermal stability of FluoDot nanoparticles showed a positive
correlation with the size of FluoDot nanoparticles. The most stable FluoDot retained 60%
of the protein secondary structure after steam sterilization holding at 121 oC for 30 min.
The shelf half-life of FluoDot24 is 710 days, which is more than 5 times longer than
unmodified protein at room temperature. After labeling with specific fluorescent dyes,
FluoDot emits different colors independent of their size, which is a major advantage over
quantum dots. Compared to free organic dyes, the photostability of FluoDot is improved
8.5 times. FluoDot is the first nanoparticles of their kind, which are water-soluble, nontoxic, biocompatible and biodegradable, with precisely controlled size, and improved
thermal stability and photostability. The properties of tunable size and improved thermal
stability provides them a large potential filed of applications such as cell imaging and
biological sensing applications.
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3.2 Introduction
The design and synthesis of a general approach to make single protein
nanoparticles (FluoDot) are reported here. Nanoparticles are a kind of particles with a
size in nanometer scale, which can be prepared from various materials such as synthetic
polymers or proteins.1 Compared to other nanoparticles used for biological applications,
protein-based nanoparticles are imperative because of their unique properties, such as
low toxicity, biocompatibility, and biodegradability.2 Protein-based nanoparticles have
been widely used for a variety of biological applications, including cell imaging, 3–5 drug
delivery,6–8 nanomedicines,9 cancer therapy,10,11 biocatalysis,12–14 and biological
sensing.15–17
In the field of synthesizing protein nanoparticles for biological systems, the size,
shape, surface chemistry, surface activity, and the degree of aggregation play critical
roles for biological applications,18 as they could affect nanoparticles binding properties,
nanoparticles

pathophysiology

and

toxicity,19 and

nanoparticle-biomolecule

or

nanoparticle-cell interactions.20–22 Polymer modification has been reported as a very
common method to prepare protein-based nanoparticles.23 However, with polymer
modification, the sizes of protein nanoparticles are difficult to control. Long polymer chains
also caused the aggregation of protein molecules. The chemistry composite is not defined,
and the surface properties of nanoparticles are not uniform. There are rare examples of
protein nanoparticles that are smaller than 20 nm, which are highly sought after for
biological applications.
Single protein nanoparticles are a kind of nanoparticles that only have one protein
molecule in each particle, wrapped with a thin layer of polymers or small molecules. The
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thin layer is about 3-5 nm thick and is highly porous.24 The thin layer covers the protein
and protects the protein from aggregation. After chemical modification on the surface of
proteins, the structure of central proteins should not change, and the binding sites on the
protein should still be active.25 There are a couple of different methods used to generate
single

protein

nanoparticles,

such

as

nanoporous

silica

shell, 26,27

polymer

modification,28,29 organoclay hollow metal nanoparticles,30 and sol-gel method.31
However, the synthesis of single protein nanoparticles is still facing numerous
challenges, including complicated surface modification of proteins for the reactions,
structure or activity loss after modifications, difficulties of precisely controlling the size or
color, restrict storage conditions, and short lifetimes. These restrictions prevent the bulk
production and practical application of these protein nanoparticles.
Bovine serum albumin (BSA) is an inexpensive protein and a waster product from
the meat industry. It has about 59 primary amines and most of them are reactive. 32 This
provides a good platform for attaching other small molecules onto the surface of BSA via
carbodiimide chemistry, which doesn’t significantly change the molecular structure of the
protein,33 which is essential for providing binding sites for ligands. BSA binds various
ligands, including fatty acids,34 hormones,35 metal ions,36 and organic chromophores.37
With these outstanding properties, BSA-based nanoparticles can potentially be applied
for small molecules carriers and deliverers.38–41
Here, we reported a modular method to synthesize a novel kind of single protein
nanoparticles (FluoDot), by combining suitable lipid molecules with the protein core to
generate a core-shell structure, followed by labeling with specific fluorescent dyes. The
lipid molecules were attached on proteins with well-defined stoichiometry via carbodiimide
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chemistry. (Scheme 3.1) The attachment does not disrupt the secondary structure of the
protein, which plays an important role in the binding of fluorescent dyes. The particle size
is tunable with two C-C bonds, by changing the carbon chain length of the lipid, thus, the
size of FluoDot is controlled at the angstrom level. The emission color of the FluoDot is
tunable based on the chromophores attached to the particles, independently from the size.
Unlike quantum dots, the size and color of FluoDot can be tuned independently.
Compared to quantum dots, fluorescent dye-labeled protein nanoparticles are
advantageous because of easier preparation, better solubilities, biocompatibility, and
biodegradability. The photostability of the chromophores was improved because they are
embedded in the hydrophobic sites and protected by the protein. In addition, the lipid shell
protects protein core from aggregation when they denatured because of heat, more
importantly, helps proteins renature at room temperature and gives proteins partial shapememory property. Improved thermal stability and shelf-life make FluoDot as a promising
candidate for biosening and cell imaging.
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Scheme 3.1
Fluorescent single protein nanoparticles synthesized with bovine serum albumin and
dicarboxylic acids via carbodiimide chemistry.
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3.3 Experimental
3.3.1 Materials
Fatty acid free bovine serum albumin (BSA) was purchased from Equitech Bio
(Kerville, TX). 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and succinic acid
were purchased from TCI America (Portland, OR). Suberic acid, dodecanedioic acid, and
tetradecanedioic acid were purchased from Alfa Aesar (Tewksbury, MA). Sodium
phosphate dibasic, sebacic acid, and ﬂuorescein isothiocyanate (FITC) were purchased
from Sigma Aldrich (Milwaukee, WI). 5-(and-6)-carboxy-x-rhodamine, succinimidyl ester
(Rox), 7-diethylaminocoumarin-3-carboxylic acid, succinimidyl ester (DEAC), and 7Methoxycoumarin-3-hydroxy succinimidyl ester (MC) were purchased from Ananspec
(Fremont, CA).
3.3.2 Synthesis of FluoDotX-N single protein nanoparticles
Five different fatty diacids, succinic acid, suberic acid, sebacic acid, dodecanedioic
acid, and tetradecanedioic acid were used to synthesize FluoDot nanoparticles (Scheme 3.2).
Dodecanedioic acid was used as the model acid, and different reaction conditions were tried
to optimize the synthesis. All the reaction conditions are summarized in Table 3.1. In general,
fatty diacid solution was prepared by dissolving 90 mM fatty diacid with 180 mM NaOH in
phosphate buffer (50 mM, pH 8.0) and stirring until completely dissolved. And then the FluoDot
nanoparticles were synthesized using EDC as the coupling agent. 90 mM EDC was added to
the above fatty diacid solution and stirred for 30 minutes, followed by adding 0.1 mM BSA and
stirring for at least 4 hours. The sample was purified by dialysis four times using a 25 kDa
molecular weight cut off dialysis membrane against 50 mM phosphate buffer (pH 8.0) to
remove excess fatty diacid molecules, hydrolyzed EDC and byproducts.
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3.3.3 Dynamic light scattering (DLS)
Hydrodynamic size of BSA and FluoDot nanoparticles nanoparticles were
monitored by means of photon correlation spectroscopy with Precision Detectors (Varian
Inc.), CoolBatch+ dynamic light scattering apparatus with 10 × 10 mm2 cuvette, 658 nm
excitation laser source with a 90° geometry. Data collection was done at room
temperature, 1 s response, 3 repetitions, and 100 accumulations. BSA and the FluoDot
nanoparticles were dissolved in 50 mM phosphate buffer, and the solutions were filtered
with 0.22 μm filters (polyvinylidene diﬂuoride, PVDF, 13 mm, Restek) before the
measurements. Precision Ellucidate v 1.1.0.9 and Precision Deconvolve v 5.5 were used
to collect and analyze the data, respectively.
3.3.4 Circular dichroism (CD)
The retention of the secondary structure was tested by circular dichroism (CD). CD
spectra were got from Jasco J-710 spectropolarimeter. There were around 0.3 μM protein
dissolved in 50 mM phosphate buffer (pH 8.0) in the samples used for measurements.
Spectra were obtained using a 0.05 cm path length quartz cuvette from 260 nm to 190
nm. The sensitivity was set as100 mdeg and the data pitch as 0.5 nm, with continuous
scanning mode, 50 nm min-1 scanning speed, 1 s response, 1.0 nm bandwidth, and three
accumulations. The baseline was measured with 50 mM phosphate buffer (pH 8.0) and
subtracted from each spectrum.
3.3.5 Transmission electron microscopy (TEM)
FluoDot24-N was diluted with distilled water to 20 µg/mL and 12 µL of sample was
drop-cast onto a TEM grid (TED PELLA, Inc., CA:Ultrathin carbon film supported by a
lacey carbon film on a 400 mesh copper grid. Product No. 01824). Whatman 1 filter paper
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was used to dab off extra solution after 3 minutes. The grid was left to dry for 2 minutes
and then 10 µL of 1% ammonium molybdate stain (ammonium molybdate dissolved in
distilled water and pH adjusted to 7 using concentrated NaOH, filtered through 0.2 µm
filter before use) was dropcast onto the sample for 15 seconds before removing excess
stain by dabbing with filter paper. The sample was then left to dry overnight before being
taken for imaging. A FEI Tecnai T12 S/TEM was used for imaging with an accelerating
voltage of 120 kV.
3.3.6 Agarose gel electrophoresis
0.5% agarose gel was prepared. 125 mg agarose was dissolved in 25 mL trisacetate buffer (40 mM, pH 7.0) by microwaving for 1 minute. The agarose solution was
then poured and stand for 30 minutes at room temperature. Samples were prepared by
mixing 10 μL protein solution (1 mg/mL) with 10 μL of agarose loading buffer (50% v/v
glycerol solution containing 0.01% m/v bromophenol blue). 15 μL of each sample was
then loaded in each well (7.5 μg of protein/well). The agarose gel was run at 100 mV for
25 minutes with Gibco BRL Model 200 power supplier. After running, the agarose gel was
stained with 20% v/v acetic acid solution containing 0.003% m/v brilliant blue R-250, and
destained with 10% v/v acetic acid solution.
3.3.7 Polyacrylamide gel electrophoresis (SDS-PAGE)
The gel contains separating gel (7.5%) on the bottom and stacking gel on the top.
The samples were prepared by mixing 10 μL of protein solution (1 mg/mL) with 10 μL
loading buffer (2% SDS, 10% beta-mercaptoethanol, BME), and heated in 80 oC water
bath for 5 minutes. 15 μL of each sample was then loaded in each well (7.5 μg of
protein/well). The gel was run at 200 mV for 30 minutes with Bio-Rad Mini Protean
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Electrophoresis apparatus. After running, the gel was stained with stain I (10% v/v acetic
acid, 10% v/v isopropanol, 0.003% m/v brilliant blue R-250) and stain II (20% v/v acetic
acid, 0.003% m/v brilliant blue R-250), and destained with 10% v/v acetic acid solution.
3.3.8 Differential scanning calorimetry (DSC)
DSC thermograms were recorded using a 6100 Nano II differential scanning
calorimeter (Calorimetry Sciences Corporation, CSC Utah). All samples were degassed
for at least 5 min prior to loading into the calorimeter, and cells were filled without air
bubbles. A constant pressure of 3 atm was applied to the calorimeter to prevent solvent
evaporation during the thermal scan. During the buffer versus buffer scan, both cells were
loaded with buffer (10 mM, pH 8.0), equilibrated for 10 min at 20 oC, and scanned from
20 to 120 oC at a scan rate of 2 oC/min. Once both heating and cooling scans were
completed for the buffer versus buffer scan, the sample cell was emptied, washed, and
filled with the desired protein solution (3 mg/mL BSA, pH 8.0). Heating and cooling scans
were recorded using parameters that were previously used with buffer versus buffer scan.
The nanocalorimeter was interfaced to a personal computer (IBM-compatible), and during
data processing, the buffer versus buffer scan was subtracted from the sample scan.
Each scan was normalized with respect to hemoglobin concentration. A second heating
cycle of the sample was used to check for the reversibility of thermal denaturation. Modelindependent parameters such as the peak transition temperature (T m) and ΔH of
denaturation (area under the curve) were calculated for each sample from these thermal
scans.
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3.3.9 Thermal stability studies by steam sterilization
The thermal stabilities of FluoDot nanoparticles and BSA were tested by steam
sterilization. The solutions of FluoDot nanoparticles and BSA (0.3 μM in 50 mM phosphate
buffer, pH 8.0) were steam sterilized in BioClave from BenchMark Scientific (Melrose, MA)
at 121 °C (with pressure around 17 psi) holding for 5, 15, or 30 minutes. Samples were
cooled down to room temperature on the bench top, and circular dichroism was measured,
and the agarose gels were run.
3.3.10 Synthesis of FluoDot24-X
Dye stock solutions were prepared by dissolving 60 mM Rox, FITC, DEAC, or MC
in DMSO or DMF. And then the dye stock solution was added into 0.1 mM of FluoDot24N solution and stirred for at least 4 hours. The ratio between the dyes and the protein was
optimized to have desired number of dyes labeled on each protein nanoparticles. The
samples were purified by ultracentrifugation with 10k cutoff, to remove free dyes and
byproducts.
3.3.11 Photostability studies
The photostability of FluoDot24-425 was tested with a 0.01 mM solution in
phosphate buffer (50 mM, pH 8.0). The sample was irradiated in a quartz cuvette with
stirring, using a Bausch and Lomb high intensity monochrometer at 425 nm with entrance
slit set to 4 and the exit slit set to 3. The absorbance intensity at 425 nm was monitored
as the function of irradiation time. The photostability of DEAC was tested in a similar way.
DEAC stock solution (in DMF) was diluted with 50 mM phosphate buffer to the same
concentration with DEAC in FluoDtot24-425 sample. And then the DEAC solution was
stirred for 4 hours to hydrolyze completely, followed by the same photostability studies.
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3.3.12 Long-term stability studies
The long-term stability of FluoDot24-425 was tested with BSA as a control. The
samples were stored under three different conditions, as solid at room temperature,
solution at 4 oC, and solution at room temperature. The solution samples had 0.2 mg/mL
FluoDot24-425 or BSA in 50 mM phosphate buffer (pH 8.0). The samples were
centrifuged at 10 rpm for 10 minutes before CD measurements. The solid samples were
prepared by drying 1 mg/mL solution with 0.2 M glucose using Savant ISS-100 SpeedVac.
Before CD measurements, the solid samples were resuspended with DI water, resulting
in 0.2 mg/mL FluoDot24-425 or BSA solution in phosphate buffer (50 mM, pH 8.0).
3.3.13 Synthesis of Hb-DDDA
Dodecanedioic acid solution was prepared by dissolving 90 mM dodecanedioic acid
with 180 mM NaOH in DI water and stirring until completely dissolved. And then 90 mM EDC
was added to the above solution and stirred for 30 minutes, followed by adding 0.1 mM
hemoglobin and stirring for at least 4 hours. The sample was purified by dialysis four times
using a 25 kDa molecular weight cut off dialysis membrane against 50 mM phosphate buffer
(pH 8.0) to remove excess dodecanedioic acid molecules, hydrolyzed EDC, and byproducts.
3.3.14 Redox activity studies of hemoglobin and Hb-DDDA
The redox activity of Hb in phosphate buffer (pH 8.0) was tested by using sodium
dithionite for the reduction of Fe (III) to Fe (II) and sodium ferricyanide to oxidize Fe (II) to Fe
(III). Sodium dithionate was added to solutions of Hb (15 μM) and Hb-DDDA (15 μM protein),
and the absorbance spectra were recorded. Similarly, the oxidation of the Fe (II) form of Hb
to the corresponding Fe (III) form was monitored by recording the Soret absorbance after the
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addition of sodium ferricyanide. The spectra of the untreated, reduced, and oxidized samples
were scaled, corrected for the dilutions, and overlaid for comparison.
3.3.15 Peroxidase-like activity study of hemoglobin and Hb-DDDA
The peroxidase-like activity of hemoglobin was used to compare the activities of
Hb-DDDA, Hb/DDDA, and Hb. Substrate guaiacol (2.5 mM) and oxidant H 2O2 (1 mM)
were added to the Hb samples solution (1 μM Hb in 10 mM phosphate buffer, pH 8.0).
Oxidized product formation was observed by monitoring the absorbance at 470 nm as a
function of time in the kinetics mode using an HP 8453 diode array spectrophotometer
(Hewlett-Packard, Palo Alto, CA). From the plot of absorbance versus time, initial
activities and specific activities were calculated and the values for Hb, Hb/DDDA, and HbDDDA have been compared.
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3.4 Results and discussion
3.4.1 Synthesis of single protein nanoparticles, FluoDot
FluoDot nanoparticles were synthesized by covalently linking one of the carboxylic
acid groups from fatty diacids to the amine groups on bovine serum albumin (BSA) using
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) as the crosslinker (Scheme 3.2).
Briefly, dicarboxylic acids were mixed with EDC with a 1:1 stoichiometry to activate one
carboxy group from each diacid. Then the activated dicarboxylic acids reacted with BSA,
resulting in the formation of amide bonds between carboxylic groups and amine groups.
Five different dicarboxylic acids were used to synthesize the FluoDot, as succinic acid,
suberic acid, sebacic acid, dodecanedioic acid, and tetradecanedioic acid. To clarify, all
formed nanoparticles were named as FluoDotX-N, where X represents the number of C
atoms attached onto BSA molecule in diameter direction.
After the synthesis, FluoDot24-N was further labeled with different fluorescent dyes,
as Rox, FITC, DEAC, and MC (the structures are shown in Scheme 3.3, followed by the
purification with ultracentrifugation to remove the free dyes and byproducts. These
labeled particles were named after the longest absorption band position of the dye used.
For example, FluoDot24-N labeled with FITC (λmax = 494 nm), was named “FluoDot24494”.
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Scheme 3.2
Synthesis of FluoDot nanoparticles by coupling the amine groups of BSA with the COOH
groups of the diacid by standard carbodiimide chemistry, followed by labeling with specific
fluorescent dyes. The particle size was tuned with increasingly longer dicarboxylic acids
analogs while the color has been tuned with particular dyes. All FluoDot samples
indicated high stability to heat (121 oC).
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Scheme 3.3
Structures and full names of reactive dyes used to label FluoDot nanoparticles.
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The stoichiometry among dicarboxylic acids, EDC, and BSA was optimized using
dodecanedioic acid (DDDA) as a model acid from a series of reaction conditions (Table
3.1), and the formation of the products was monitored by agarose gel electrophoresis
(Figure 3.1). When the ratio between DDDA and EDC was varied from 1:1 to 1:2, the
mobility of the products was slower as both carboxylic acid groups on each DDDA
molecule were activated, which increases the possibility of cross-linking among BSA
molecules. Crosslinked BSA particles had a much larger size than single BSA particles,
which leads to a slower mobility on the agarose gel. The ratio between DDDA and BSA
was varied from 300:1 to 1200:1. The agarose gel showed that, with a mole ratio between
diacid and BSA of 900:1, active amine groups on BSA reacted completely without crosslinking among BSA molecules. And this stoichiometry was applied to other dicarboxylic
acids used in this study. Formed nanoparticles are water-soluble, and the sizes, charges,
structures, and stabilities were studied as described below.
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Table 3.1
Different reaction conditions by varying the concentrations of BSA, EDC, and DDDA used
for the synthesis of FluoDot24-N, in 50 mM phosphate buffer (pH 8.0), at 25 oC.

Figure 3.1
Agarose gel electrophoresis of synthesized nanoparticles under different reaction
conditions. The agarose gels were run with 40 mM tris-acetate buffer, pH 7.0.
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3.4.2 FluoDotX-N with tunable size at angstrom scale
The hydrodynamic size of FluoDot nanoparticles was determined by dynamic light
scattering (DLS). All different types FluoDot nanoparticles showed a sharp size
distribution according to the DLS (Figure 3.2). The size varies from 9 nm to 11 nm,
depending on the fatty acids used. All the DLS results are summarized in Table 3.2.
Compared to the size of BSA molecules, FluoDot nanoparticles are bigger, but smaller
than the diameter of two BSA molecules, demonstrating the formation of single protein
nanoparticles. Furthermore, the radius linearly varied as a function of the number of
carbon atoms in the fatty diacids. The slope was determined as 1.29 ± 0.06 Å, which is
slightly shorter than the C-C single bond length, 1.54 Å. (Figure 3.3a)
The morphology and size of FluoDot24-N was further examined by transmission
electron microscopy (TEM) (Figure 3.3b). TEM sample was prepared with ammonium
molybdate stain. The image confirmed that FluoDot24-N has the size of around 10 nm
with a sharp size distribution (Figure 3.3c) and nearly spherical shape.
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Figure 3.2
Dynamic light scattering data of (a) BSA, (b) FluoDot8-N, (c) FluoDot16-N, (d) FluoDot20N, (e) FluoDot24-N, and (f) FluoDot28-N.

Table 3.2
Summary of DLS data of BSA, FluoDot8-N, FluoDot16-N, FluoDot20-N, FluoDot24-N,
and FluoDot28-N. The average size and standard deviation were calculated based on
three measurements of each sample.
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Figure 3.3
(a) Plot of radii vs carbon chain length, with the linear fit that gives a slope of 0.129 ±
0.006 nm and Y-intercept of 3.5 nm. (b) TEM image of FluoDot24-N stained with
ammonium molybdate indicating a particle size of 10 nm, consistent with the DLS data.
(c) Histogram of frequency vs FluoDot24-N diameter extracted from the TEM image.
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3.4.3 Charge studies of FluoDot nanoparticles
The reaction progress was monitored by zeta potential (Figure 3.4a). After
activated carboxylic acids were added into protein solution, the charge of protein
nanoparticles was getting more and more negative. During the reaction, positively
charged amine groups are modified with negatively charged carboxyl group. With longer
reaction time, the protein nanoparticles become more negatively charged. The zeta
potential changed from -5 to -20 mV.
The net charge of BSA and FuoDot nanoparticles was also studied by agarose gel
electrophoresis. In the agarose gel (Figure 3.4b), all the FluoDot nanoparticles moved
further toward the positive electrode than BSA and were at a similar position. As the DLS
and TEM showed above, the size of FluoDot nanoparticles was similar to that of
unmodified BSA, but slightly bigger. As the pore size of 0.5% agarose gel that used in
this study was determined as hundreds of nanometers, compared to which the size of
BSA and FluoDot nanoparticles are on the same scale and cannot be separated on the
agarose gel based on the size. Because of the reaction happed on the positively charged
amine groups and the addition of negatively charged carboxylic acid groups, the charge
of FluoDot nanoparticles is expected to be more negative than unmodified protein.
Therefore, the separation of BSA and FluoDot nanoparticles on the agarose gel is mainly
because of the change of net charge of protein, rather than the change of size.
The physical mixture of BSA and each diacid and the reaction mixture of BSA and
EDC without diacids presence were also studies as controls. The physical mixtures were
prepared by mixing BSA and each diacid with the same concentrations used in the
chemical conjugates, but without EDC added. The interaction between BSA and diacids
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in these physical mixtures is physical binding instead of chemical linking. On the agarose
gel, the physical mixtures had similar mobility with pure BSA (Figure 3.4 Lanes 1-6),
indicating that the physical interaction between BSA and diacids doesn’t change the size
or the charge of the protein. The change on the mobility of the chemical conjugates is
further confirmed as a result of the chemical reactions happened on the protein. The
reaction mixture of BSA and EDC without any diacids presetting was also tested as a
control (Figure 3.4 Lane 7). The reaction mixture moved slower toward the positive
electrode on the agarose gel. The charge of the product of this reaction mixture should
be similar with unreacted BSA, as one positively charged amine group reacts with one
negatively charged carboxyl group. Without diacids, EDC crosslinked BSA molecules,
and bigger particles were generated. As a result, the slower mobility is due to the increase
in the size.
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Figure 3.4
(a) Zeta potential of the reaction mixture versus the reaction time. (b) Agarose gel
electrophoresis photograph of FluoDot nanoparticles (Lanes 2-6), compared to
unmodified BSA (Lane 1). (c) Agarose gel electrophoresis photograph of the physical
mixtures of BSA and corresponding diacids (Lanes 2-6) and the reaction mixture of BSA
and EDC without diacids presenting (Lane 7), compared with unmodified BSA (Lane 1).
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3.4.4 Studies of molecular weight by SDS-PAGE
SDS-PAGE was used to test the formation of the FluoDot nanoparticles according
to the molecular weight of samples (Figure 3.5). On the SDS-PAGE, there was no band
showed at high molecular weight position, which indicates that there was no crosslinking
among protein molecules and confirms the formation of single protein nanoparticles. The
band position of FluoDot is similar to unmodified BSA, but smear, because after
modification with DDDA, BSA molecules was covered with a layer of carbon chains and
negatively charged carboxylic groups on the surface. When FluoDot nanoparticles were
dissolved in SDS micelles, SDS micelles can’t block FluoDot nanoparticles completely,
and the carboxylic acid groups are still exposed to the solvent. The charge of SDS/BSA
is just the strong negative charge from SDS micelles, while the charge of SDS/FluoDot is
an addition of the charge SDS micelles and the charge of carboxylic groups on FluoDot
nanoparticles.
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Figure 3.5
SDS-PAGE of native BSA, the physical mixture of BSA and FluoDot24-N.
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3.4.5 Structure retention of FluoDot nanoparticles
The structure retention of BSA before and after the attachment of fatty acids was
tested with circular dichroism (CD) in the UV region (260 nm-190 nm) (Figure 3.6). The
CD spectra were normalized with concentrations determined by UV-Vis absorbance
spectroscopy, using the know extinction coefficient of BSA, 43824 M-1 cm-1. The shape
and peak intensity of CD spectra of FluoDot nanoparticles are nearly identical to those of
BSA (Figure 3.6, black curve). The ratio between the intensities at 222 nm and 208 nm
didn’t change obviously either. The peak intensity at 222 nm of each samples was
compared to unmodified BSA to determine the extent structure retention, and the results
are summarized in Figure 3.6b. All the FluoDot nanoparticles retained about 100% of the
secondary structure of the native BSA. Based on these, we concluded that the protein
secondary structure was not significantly affected by the attachment of diacids via EDC
chemistry.
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Figure 3.6
(a) Circular dichroism (CD) curves of BSA (black), FluoDot8-N (red), FluoDot16-N (green),
FluoDot 20-N (brown), FluoDot24-N (blue), and FluoDot28-N (violet), in 50 mM phosphate
buffer (pH 8.0). The blank was measured with phosphate buffer (50 mM, pH 8.0), shown
as black dash line, and subtracted from each spectrum. (b) Plot of percent secondary
structure retention. Percentages were calculated by dividing the intensity of each
spectrum at 222 nm by the intensity of the unmodified BSA at 222 nm.
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3.4.6 Elemental analysis
The number of fatty acid molecules attached onto each BSA molecule was
analyzed by elemental analysis. Covalent attachment of fatty acid molecules was
expected to increase the ratio of C:N, and the number of fatty acid molecules on the BSA
was calculated by comparing C:N ratio of FluoDot nanoparticles with BSA. FluoDot24-N
and FluoDot28-N were used as two examples to figure out the composition. After the
reaction, the ratio of C:N increased from 3.95 to 4.63. As the product was purified by
dialysis, to remove free DDDA and byproduct from EDC chemistry, the increase of C:N
only corresponds to the addition of carboxylic acids. As the EDC chemistry happens on
primary amines, DDDA was attached to the lysine residues on BSA.
3.4.7 Differential scanning calorimetry
The influence of the diacid conjugation on protein stability was evaluated by
recording the DSC thermograms of BSA, DDDA, BSA/DDDA, and FluoDot24-N solutions
in phosphate buffer (Figure 3.7). The thermogram of BSA (Figure 3.7a) shows that
unmodified BSA begins to denature at about 50 oC with another transition peak at around
67 oC. And there is a negative peak at around 115 oC, indicating the denaturation and
crosslinking among protein molecules. Pure DDDA solution (Figure 3.7b) didn’t show an
obvious thermal transition in DSC. The BSA/DDDA physical mixture (Figure 3.7c) shows
a peak that is much broader from 60 to 80 oC. FluoDot24-N (Figure 3.7d) started showing
a transition from 60 oC, with a maximum peak at around 110 oC. It is notable that there is
not a negative peak in the thermogram of FluoDot24-N, indicating there was no
crosslinking among FluoDot24-N nanoparticles, up to 120 oC.
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The integrated area under the curve is the enthalpy of denaturation, and there was
a significant difference in the enthalpy values obtained for BSA, BSA/DDDA, and
FluoDot24-N (Table 3.3). BSA had denaturation enthalpies of 111.7 kcal/mol, whereas
FluoDot24-N conjugate showed a significantly higher ΔH (521.3 kcal/mol), which is
greater than that of BSA/DDDA (213.6 kcal/mol). The value is higher than the sum of the
enthalpies of BSA by ∼400 kcal/mol. Such a substantial increase in the denaturation
enthalpy is a welcome change and can be exploited to improve the thermal stability of
FluoDot24-N. Hence, the thermal stability under steam sterilization and storage stability
of FluoDot24-N at room temperature is expected to be significantly better than that of the
parent BSA.
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Figure 3.7
DSC thermograms of (a) BSA, (b) DDDA, (c) BSA/DDDA, and (d) FluoDot24-N. The
molar heat capacity profiles of BSA (3 mg/mL, ~40 µM), DDDA (1.5 mM), BSA/DDDA (40
μM protein, 1.5 mM DDDA), and FluoDot24-N (40 μM protein) were recorded in 10mM,
pH 8.0 phosphate buffer at a scan rate of 2 oC/min. The quantitative values of the
corresponding thermodynamic parameters are listed in Table 3.3.
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Table 3.3
Denaturation Temperatures and ΔH Values for BSA, DDDA, BSA/DDDA, and FluoDot24N in 10 mM phosphate buffer pH 8.0 at a scan rate of 2 oC/min
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3.4.8 Thermal stability tested by steam sterilization
The thermal stabilities of BSA and FluoDot nanoparticles were studied by steam
sterilization. The samples were heated at 121 oC for 5, 15, or 30 minutes, and then cooled
at room temperature, followed by taking the CD spectra and running the agarose gels.
Cooling process took about 30 minutes, and the CD didn’t show any obvious difference
after 10 hours cooling.
The CD results were summarized in Figure 3.8a, where the secondary structure
retention was plotted versus the time length of steam sterilization. The extent of structure
retention was determined by dividing the intensity at 222 nm after stem sterilization by
that before the heating treatment. After heating for 5 min and then cooling, only
unmodified BSA turned to a random coil structure, while all the FluoDot nanoparticles
folded back to the original structure at some degree. Unmodified BSA retained about 38%
of the intensity at 222 nm, while FluoDot 28-N retained about 73% of secondary structure.
The ratio between the intensities at 222 nm and 208 nm of BSA decreased from 0.9 to
0.6, while that of FluoDot28-N decreased to 0.75. All the results are summarized in Table
3.4.
For longer time of steam sterilization, FluoDot8-N and FluoDot16-N also turned to
random coil structure after the heating and cooling process, while FluoDot24-N and
FluoDot28-N folded back. After steam sterilization for 15 minutes, FluoDot24-N and
FluoDot28-N retained 59% and 70% of the protein secondary structure, respectively. And
ratio between the intensities at 208 and 222 nm was 0.69 and 0.72. After steam
sterilization for 15 minutes, FluoDot24-N and FluoDot28-N retained 55% and 61% of the
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protein secondary structure, respectively. And ratio between the intensities at 208 and
222 nm was 0.65 and 0.70. All the CD curves are shown in Figure 3.9.
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Figure 3.8
(a) The extent of the secondary structure retention of BSA (black), FluoDot8-N (red),
FluoDot16-N (orange), FluoDot24-N (blue), and FluoDot28-N (violet) after steam
sterilization vs steam sterilization time. (b) Agarose gel electrophoresis of BSA (Lanes 14) and FluoDot28-N (Lanes 5-8), before and after steam sterilization

Table 3.4
Summary of the secondary structure retention of BSA and all the FluoDot samples after
steam sterilization for 5, 15, and 30 minutes.

86

Figure 3.9
(a-e) CD spectrum of BSA, FluoDot8-N, FluoDot16-N, and FluoDot 24-N, and FluoDot28N before and after steam sterilization and cooling process. (f) The ratio of CD intensities
at 222 nm and 208 nm as a function of steam sterilization time.

87

The change in charge or the size of protein before and after steam sterilization was
also tested by agarose gel electrophoresis. After steam sterilization, BSA showed a
dragging band at slightly lower position, which is due to the denaturation and aggregation
of BSA by heating at high temperature. The dragging band is longer and the band of
original BSA is lighter with increasing steam sterilization time. On the contrary, the band
of FluoDot28-N is at about the same position before and after steam sterilization, but
slightly closer position to the positively electrode. Similar results were observed on other
FluoDot nanoparticles. (Figure 3.8b and Figure 3.10)
BSA and FluoDot24-N didn’t show any structure at 90 oC, demonstrating protein
refolding (data not shown). All these results confirm our hypothesis that, the modification
with dicarboxylic acid of BSA improved the thermal stability and denaturation reversibility
of protein, and the thermal stability improved with increased length of carbon chains
attached. Proposed procedure of the changes of the protein was shown in Scheme 3.4.
Both BSA and FluoDot nanoparticles are at undenatured state essentially. When the
samples are heated in the autoclave, the protein is denatured and lose the structure. After
cooling, unmodified BSA is not able to fold back to the original structure, while FluoDot
nanoparticles are.
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Figure 3.10
Agarose gel electrophoresis of FluoDot8-N, FluoDot16-N, and FluoDot 24-N before and
after steam sterilization and cooling process.

Scheme 3.4
Nearly reversible denaturation by steam sterilization and renaturation by cooling to room
temperature observed with FluoDot nanoparicles.
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3.4.9 Synthesis of FluoDot24-X
As a potential application, we labeled FluoDot24-N with reactive fluorescent dyes
to give particles multiple different colors. The color is tunable based on the fluorescent
dye used, and the color tunability is independent of the size of the FluoDot nanoparticles.
In this nomenclature, the number at the end shows the wavelength of the maximum
absorption peak of the FluoDot24-N nanoparticles. Four different fluorescent dyes were
used, as Rox, FITC, DEAC, and MC, and synthesized FluoDot nanoparticles were named
as FluoDot24-580, FluoDot24-494, FluoDot24-425, and FluoDot24-350. After purification
by ultracentrifugation to remove free dyes and byproducts, there were no free des can be
detected from agarose gel electrophoresis. The absorbance and fluorescence spectra
after purification are shown in Figure 3.11.
The charge and the size were studied by agarose gel electrophoresis. The agarose
gel was run at pH 5.0 or pH 7.0 to separate free dyes and FluoDot24-X. The agarose gel
was imaged under the UV light to reveal the positions of FluoDot24-X and free dyes
(Figure 3.12). For example, in FluoDot24-425 (Figure 3.12c, Lane 3), only a single band
was shown and there was no band corresponding to the unreacted DEAC (Lane 4), which
confirmed the purity of FluoDot24-425. The same agarose gel was then stained with
Coomassie Blue and imaged under the ambient light, to reveal the position of the protein.
It shows that the position of in FluoDot24-N and FluoDot24-425 are about the same, which
demonstrates that the labeling of fluorescent dyes doesn’t change either the size or the
charge. The mobility of FluoDot24-N and FluoDot24-425 are low at pH 5.0, because of
the low solubility of FluoDot nanoparticles at low pH. The agarose gel at pH 7.0 showed
that the relative charge of FluoDot nanoparticles doesn’t change.
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Figure 3.11
Absorbance (a) and emission (b) spectra of FluoDot24-350, FluoDot24-425, FluoDot24494, and FluoDot24-580.
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Figure 3.12
(a-d) Agarose gel electrophoresis of FluoDot24-580, FluoDot24-494, FluoDot 24-425,
and FluoDot24-350. Unmodified BSA, FluoDot24-N, and free dyes were used for
comparison. The gels were observed under 365 nm UV light, and then stained and
destained as described above to observe the protein location. The gels were run with pH
7.0 tris-acetate buffer, except the gel for FluoDot 24-425 was run with pH 5.0 tris-acetate
buffer. (e-f) Absorbance spectra of FluoDot nanoparticles compared to corresponding
fluorescent dyes in aqueous solutions.
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The size of FluoDot24-425 was tested by DLS, which showed a sharp size
distribution at 10 nm (Figure 3.13). The size is about the same with unlabeled FluoDot24N, which demonstrates that the labeling with fluorescent dyes didn’t disturb the size of
FluoDot nanoparticles.
The absorbance and emission spectra were taken to study the optical properties
of FluoDot24-X samples. The maximum absorbance wavelength and emission
wavelengths are summarized in Table 3.5. The labeling efficiency was also calculated.
After purification, the concentrations of each dye and protein were calculated using the
absorbance intensities and extinction coefficients. Firstly, the concentration of the dye
was calculated using the absorbance intensity at the maximum absorbance wavelength.
And then the absorbance at 280 nm induced by the dye was calculated by multiplying the
dye concentration with the extinction coefficient of the dye at 280 nm. The concentration
of the protein was then calculated by subtracting the absorbance at 280 nm induced by
the dye from the total absorbance at 280 nm, following by dividing by the extinction
coefficient of protein at 280 nm. the labeling efficiency of each dye was calculated by
dividing the initial concentration of the dye by the concentration of labeled dye.
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Figure 3.13
DLS data of FluoDot24-425, showing the hydrodynamic size of FluoDot24-425 is 10 nm,
which is about the same with FluoDot24-N.

Table 3.5
Summary of the absorbance and emission wavelengths and labeling efficiencies of
FluoDot samples.
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3.4.10 Photostability of FluoDot24-425
The photostability of FluoDot24-425 was tested in solution phase under the
irradiation at 425 nm. The absorbance spectrum was taken at specific time intervals. The
absorbance spectra are shown in Figure 3.14a. The intensity of absorbance at 425 nm
was plotted as a function of irradiation time (Figure 3.14b). It took about 3 hours for
FluoDot24-425 to decrease the absorbance intensity to 90%, while the absorbance of
free DEAC decreased to 80% after 50 minutes of irradiation. The half-life of free DEAC
and FluoDot24-425 was estimated by linearly fitting the intensity versus irradiation time
curves and estimating the time length for the absorbance intensity to get 50%. The halflife of free DEAC in aqueous solution was determined as 121 minutes, while the half-life
of FluoDot24-425 was determined as 1071 minutes, which is about 9 times higher than
that of free DEAC.
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Figure 3.14
(a) The photostability study of FluoDot24-425. The absorbance spectra of FluoDot24-425
were taken after different time lengths of irradiation by a monochromator at 425 nm. (b)
The absorbance of FluoDot24-425 at 425 nm was plotted versus the irradiation time at
425 nm. Free DEAC in aqueous solution was used for comparison.
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3.4.11 Long-term stability studies
The long-term stability of FluoDot24 was tested at 4 oC and room temperature, in
solution phase or solid phase. For storage and transportation, the samples in the solid
phase are more convenient for commercialization. Here we tested the storage stability of
Fluodot24 and BSA in the solid phase with glucose matrix which helps with the size
retention. FluoDot24 solution was stored at 4 oC. The solid FluoDot24-425 was prepared
by drying FluoDot24-425 solution in glucose matric as described in the experimental
section, and then stored at room temperature. BSA solid sample was prepared by drying
BSA solution with glucose matrix was used as the control and stored under the same
condition. CD spectra were taken after storage for different time lengths. The intensity at
222 nm was used as the standard to be compared with the activities of freshly synthesized
FluoDot24 sample. FluoDot24 sample stored in solution phase at 4 oC maintained more
than 90% of the secondary structure after stored for 213 days. The FluoDot24 sample
stored in solid phase at room temperature also retained about 90% of the secondary
structure after 142 days. For comparison, unmodified BSA that was stored in solid phase
at room temperature lost more than 30% of the secondary structure after 86 days. The
approximate half-life for storing BSA solid in the glucose matrix at room temperature is
134 days, while that of FluoDot24 is about 710 days.
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Figure 3.15
(a) CD spectra of FluoDot24 stored in solid phase at room temperature. (b) CD spectra
of FluoDot24 stored in solution phase at 4 oC. (c) CD spectra of BSA stored in solid phase
at room temperature. (d) The protein secondary structure retention of FluoDot24 and BSA
plotted versus storage time. The structure retention was determined by the percentage of
the CD intensity at 222 nm.
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3.4.12 Synthesis and gel electrophoresis of Hb-DDDA
Hb-DDDA was synthesized following the same procedure with FluoDot24-N.
Similar to the synthesis of FluoDot, EDC was used as the crosslinker to chemically
conjugate the carboxy group from the fatty acids with the amine groups from the protein.
Similarly, the reaction product of such reaction should be more negatively charged than
unmodified protein. To study about the charge change in the reaction, agarose gel
electrophoresis was used to observe the mobility of the protein.
First, the gel was run at pH 7.0 (Figure 3.16a). The isoelectric point of hemoglobin
was reported as 6.8. As a result, unmodified hemoglobin moved to the positively electrode
with a sear band. Compared to unmodified hemoglobin, Hb-DDDA moved faster to the
positive electrode. As discussed above, the change in the size of the particles wouldn’t
change the mobility of the samples on the agarose gel compared to the pore size of the
agarose gel. The change in the mobility is due to the chemical reaction happened on the
protein. As the isoelectric point is close to 7, free hemoglobin showed a smear band. To
separate unmodified hemoglobin and BSA-DDDA better, the gel was run at pH 5.1
(Figure 3.16b). As the pH is lower than the isoelectric point of hemoglobin, unmodified
hemoglobin moved to the negative electrode. The physical mixture of hemoglobin and
DDDA had nearly identical mobility with hemoglobin, indicating that the physical
interaction between hemoglobin and DDDA doesn’t change the mobility of the protein.
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Figure 3.16
Agarose gel electrophoresis images of (a) hemoglobin and Hb-DDDA run at pH 7.0 and
(b) hemoglobin, Hb/DDDA, and Hb-DDDA run at pH 5.1. The gels were run with 40 mM
tris-acetate buffer.
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3.4.13 UV-Vis spectroscopy and circular dichroism studies
The Soret band of unmodified Hb indicated a peak maximum at 406 nm (Figure
3.17a, black curve) The Soret bands of Hb and Hb-DDDA have nearly identical intensity,
whereas the peak of Hb-DDDA shifted to 412 nm from that of unmodified hemoglobin,
406 nm. The important observation is that the extinction coefficients of Hb and Hb-PAA
are identical, and the data suggest that the heme environment is not influenced by the
covalent conjugation of lysine side chains of Hb with the carboxyl groups of diacid.
In the range of 500-600 nm in the absorbance spectra (Figure 3.17b), unmodified
hemoglobin and Hb-DDDA showed a notable difference, that hemoglobin showed double
peaks at 540 and 575 nm, which indicates the oxyhemoglobin state. However, Hb-DDDA
showed double peaks at 540 and 565 nm. The shift of one of these double peaks
demonstrates the transition from oxyhemoglobin to carboxyhemoglobin. This change
confirms the success of the reaction further, and the formation of the amide bonds and
the addition of the carboxy groups changed the optical properties of hemoglobin.
Changes in protein secondary structure due to the covalent conjugation were
assessed by comparing the UV-CD spectra of the conjugate with that of unmodified
hemoglobin (Figure 3.18a). The UV-CD spectra are very sensitive to the changes in
protein secondary structure, and they serve as excellent probes for examining protein
structure. The CD spectrum of unmodified Hb indicated double peaks at 208 and 222 nm
(Figure 3.18a, black curve), and these are nearly the same as those of Hb-DDDA (Figure
3.18a, red curve), recorded under the same conditions. As only minor differences noted
between the spectrum of Hb-DDDA and that of Hb, we conclude that the secondary
structure of the protein has been retained to a large extent.
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The Soret CD of hemoglobin is a sensitive measure of the asymmetry of the heme
environment in hemoglobin. The Soret CD was used to evaluate changes in the heme
environment (Figure 3.18b). The maximum peak position of the Soret CD spectra of
unmodified hemoglobin (black curve) and Hb-DDDA (red curve) are the same, but the
intensity of the peak decreased by about 80%. These changes demonstrate that the heme
coordination environment in the conjugate was changed because of the chemical reaction.

102

Figure 3.17
UV-Vis spectra of Hb and Hb-DDDA (2 μM protein) recorded in 50 mM phosphate buffer
(pH 8.0) with 1 cm path length. The Soret bands of Hb (black line) and Hb-DDDA (red
line) have nearly identical intensity, whereas the peak of Hb-DDDA shifted to 412 nm from
that of unmodified hemoglobin, 406 nm.
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Figure 3.18
(a) Far-UV CD spectra of unmodified Hb (black curve) and the Hb-DDDA (red curve).
both samples contained the same amount of Hb (15 μM protein 50 mM phosphate buffer,
pH 8.0) with 0.05 cm cuvette pathlength. The spectra were normalized by the
concentrations of the protein presented in the solution calculated from absorbance
intensities. (b) Soret CD of Hb and Hb-DDDA (15 μM protein 50 mM phosphate buffer,
pH 8.0) with 1 cm cuvette pathlength.
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3.4.14 Redox activity studies of Hb-DDDA
The redox activity of the heme prosthetic group in Hb and Hb-DDDA was tested.
The Fe (III) center present in hemoglobin undergoes efficient redox chemistry, and the
redox reaction can be monitored by UV-Vis spectroscopy. Maintaining the Fe (II) state of
hemoglobin under physiological conditions is critical to its biological activity. The addition
of sodium dithionite reduces the Fe (III) form of Hb to the Fe (II) form, and the reaction
equation is shown in Equation 3.1. Such chemical reaction would change the double
peaks presenting in the range of 500-600 nm. this reduction reaction is reversible, the
addition of potassium ferricyanide to the Fe (II) form of Hb is expected to revert to the Fe
(III) state, and the reaction is shown in Equation 3.2.
S2O42- + 2Fe3+ + 2H2O → 2SO32- + 2Fe2+ + 4H+
Fe2+ + Fe(CN)63- → Fe3+ + Fe(CN)64-

Equation 3.1
Equation 3.2

First, the redox activity of unmodified hemoglobin was tested using the reactions
described above, the color changes of the solution is shown in Figure 3.19.

The

hemoglobin solution in 50 mM phosphate buffer (pH 8.0) was light brown at room
temperature. After sodium dithionite was added, the color changed to maroon during the
reaction. After the reduction reaction was completed, potassium ferricyanide was added,
and the solution turned to green color. The absorbance spectra were taken to stuy about
the hemoglobin status (Figure 3.20). Compared to the absorbance spectrum of the
original hemoglobin solution (black curve), after the addition of sodium dithionite, the
double peaks stayed for 2 cycles, and then there was a single peak at 560 nm rather than
the double peaks (red, green, blue, and purple curves). The change of the peaks indicates
that after two cycles of the redox reactions, hemoglobin at Fe (II) state transferred from

105

oxyhemoglobin to hemoglobin. After the addition of potassium ferricyanide, the double
peaks in the range of 500-600 nm disappeared, and two new peaks showed up at 500
and 630 nm (overlapped curves). The changes demonstrate that the addition of sodium
dithionite and potassium ferricyanide changed the hemoglobin from oxyhemoglobin to
methemoglobin.
Similarly, the same experiments were carried out with Hb-DDDA. The photographs
of the reaction mixture are shown in Figure 3.21. The addition of sodium dithionite to
Hb-DDDA induced the cloudiness of the solution. According to the reaction equation
shown in Equation 3.1, the addition of sodium dithionite will case the formation of H +,
and the acidity of the solution will cause the precipitation of Hb-DDDA. To confirm this
hypothesis, we first centrifuged the solution. After centrifugation, the precipitate showed
a dark brown color, while the supernatant was nearly clear, implying the precipitate is HbDDDA. Furthermore, we added sodium hydroxide to neutralize the solution. After the
addition of sodium hydroxide, the solution cleared up and the precipitated dissolved b ck
to the solution. Similar to hemoglobin, the addition of sodium dithionite changed the
solution color from light brown to marron. Different from hemoglobin, the addition of
potassium ferricyanide only changed the color of the solution back to light brown instead
of green. The absorbance spectra were also taken to study about the optical property’s
changes during the redox reactions (Figure 3.22). After the addition of sodium dithionite,
the intensities of the double peaks in the range of 500-600 nm increased. The ratio
between the peak intensities at 540 and 565 nm decreased. After the addition of
potassium ferricyanide, the ratio between the intensities of the double peaks changed
back to the original ratio, and the peaks had slightly lower intensities than the original
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ones. It’s notable that the redox reactions happened on the iron center of Hb-DDDA didn’t
change the status of hemoglobin. The absorbance spectrum indicates retention of
carboxyhemoglobin derivative. Regardless of the differences about the redox activity
results of unmodified hemoglobin and Hb-DDDA, Hb-DDDA retained its redox activity.
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Figure 3.19
Photographs of the hemoglobin solution before and after the addition of sodium dithionite
and potassium ferricyanide. The reaction was carried out in 50 mM phosphate buffer, pH
8.0.

Figure 3.20
The absorbance spectra of hemoglobin before and after the addition of sodium dithionite
and potassium ferricyanide. The back curve is the original spectrum of hemoglobin. Each
addition of sodium dithionite and potassium ferricyanide was regarded as a cycle of the
redox reactions, and the overlapped curves are the absorbance spectra after each cycle
of the reaction. The red, brown, green, blue, and purple curves show are the absorbance
spectra after the addition of sodium dithionite in each cycle. The reactions and
measurements were carried out in 50 mM phosphate buffer, pH 8.0.
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Figure 3.21
Photographs of the Hb-DDDA solution before and after the addition of sodium dithionite
and potassium ferricyanide. The reaction was carried out in 50 mM phosphate buffer, pH
8.0.

Figure 3.22
(a) The absorbance spectra of hemoglobin before and after the of addition of sodium
dithionite and potassium ferricyanide. The black curve showed the original spectra, the
purple curve was recorded after the addition of sodium dithionite, and the red curve was
recorded after the addition of potassium ferricyanide. The reactions and measurements
were carried out in 50 mM phosphate buffer, pH 8.0.
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3.4.15 Peroxidase-like activity studies of Hb-DDDA
One of the most interesting properties about hemoglobin is that hemoglobin can
act as a peroxidase and catalyze the oxidation of lipids and phenolic derivatives by
hydrogen peroxide as the oxidant. For example, guaiacol can be oxidized by H2O2 in the
presence of peroxidase to generate quinone. The reaction scheme is shown in Scheme
3.5. The product produced shows a deep red color because of the formation of dimeric
and higher aggregates of the phenol, which absorb at 470 nm. The peroxidase-like
catalytic activities of unmodified hemoglobin, Hb/DDDA, and Hb-DDDA under the same
reaction conditions of concentration, buffer, pH, and temperature are tested (Figure
3.23a). The absorbance intensity at 470 nm was monitored as function of reaction time.
The reaction mixtures without H2O2, without protein, or only with DDDA were used as
controls. In the control experiments, all the reaction mixtures showed no formation of the
product after 10 minutes, indicating that the protein and H2O2 are both essential for the
reaction, and DDDA doesn’t catalyze such reaction. Compared to the kinetic curve of
unmodified hemoglobin (black curve), the physical mixture Hb/DDDA showed a similar
activity. The chemical conjugate Hb-DDDA lost some of the catalytic activity of
hemoglobin after the conjugation. The specific activities were also calculated according
to the kinetic curves (Figure 3.23b). The physical mixture Hb/DDDA retained about 100%
activity of the unmodified hemoglobin, while Hb-DDDA retained more than30% activity.
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Scheme 3.5
The reaction scheme of the oxidation of guaiacol by hydrogen peroxide, catalyzed by
peroxidase.

Figure 3.23
(a) Peroxidase-like activities of unmodified hemoglobin (black curve), the physical mixture
of hemoglobin and DDDA (Hb/DDDA, green curve), and Hb-DDDA (red curve). Activities
were measured with 0.5 mM H2O2 and 2.5 mM guaiacol in 50 mM phosphate buffer (pH
8.0) at room temperature, with 1 µM protein presenting in the solution. The reaction
mixture without protein, only with DDDA, and without H2O2 were used as controls. (b)
Specific activities of unmodified hemoglobin, Hb/DDDA, and Hb-DDDA calculated from
the kinetic curves.
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3.4.16 Differential scanning calorimetry studies of Hb-DDDA
The influence of the fatty diacid conjugation on protein stability was evaluated by
recording differential scanning calorimetry studies of Hb and Hb-DDDA solutions (Figure
3.24). The studies were carried out with the sample solutions with 3 mg/mL protein
presenting in 50 mM phosphate buffer (pH 8.0). The thermograms show that unmodified
hemoglobin (black curve) starts to denature at about 50 oC with a peak maximum of 60
oC.

When the temperature was higher than 70 oC, there was a negative peak showing,

which indicates the crosslinking among the hemoglobin molecules. Compared to
unmodified hemoglobin, Hb-DDDA has the maximum peak at higher temperature around
70 oC (red curve). Moreover, there was no negative peak up to 120 oC. From the shift of
the maximum peak and the disappearance of the negative peak from the thermograms,
we conclude that the conjugation of fatty diacids improves the thermal stability of the
protein by increasing the denaturation temperature and protecting the protein from
crosslinking at high temperature.
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Figure 3.24
DSC thermograms of Hb (black curve) and Hb-DDDA (red curve). The molar heat
capacity profiles of unmodified hemoglobin and Hb-DDDA were recorded in 50 mM
phosphate buffer (pH 8.0) and monitored versus the temperature at a scan rate of 2
oC/min.
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3.4.17 Thermal stability studies of Hb-DDDA by steam sterilization
The effect of high temperature on the structure and biological activity was
investigated by subjecting the samples to steam sterilization in phosphate buffer. The
ability to sterilize a material can influence its potential use as a biomaterial. Samples of
unmodified hemoglobin, Hb/DDDA, and Hb-DDDA dissolved in phosphate buffer were
heated to 121 oC at 17 psi for 5 min. After the samples were cooled at room temperature
for 30 minutes, the samples were centrifuged at 10k rpm for 10 minutes to separate the
precipitate from the solution, if any. The photographs were taken before and after steam
sterilization and centrifugation (Figure 3.25). After steam sterilization, most of unmodified
hemoglobin precipitated because of the denaturation by the high temperature, as well as
the physical mixture Hb/DDDA. On the contrary, the chemical conjugate Hb-DDDA didn’t
show any precipitation after steam sterilization, this observation is consistent with the
DSC study, that the conjugation of fatty acids protects hemoglobin from aggregation and
precipitation.
The absorbance spectra were taken after steam sterilization and cooling (Figure
3.26). For unmodified hemoglobin, the peak position shifted from 406 nm to 408 nm. And
the maximum intensity decreased more than 80% compared to the original intensity.
Similar to Hb, the absorbance peak of the physical mixture Hb/DDDA also shifted from
406 to 408 nm, with a nearly 80% peak intensity loss. For the chemical conjugate, HbDDDA, there was no shift of the peak position, and it retained nearly 90% of the peak
intensity. The absorbance data is summarized in Table 3.6.
The structure of the protein after heating was studied by circular dichroism (Figure
3.27). The peak intensities at 208 and 222 nm were used to evaluate the structure change
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of the protein, and the summary of the CD data is shown in Table 3.7. After steam
sterilization, both Hb and the physical mixture Hb/DDDA more than 85% secondary
structure, while Hb-DDDA retained more than 80% secondary structure.
The peroxidase-like activity of each sample after heating was monitored, as
described earlier. The specific activity retention was determined by dividing the original
activity of the same sample by the activity after steam sterilization The activities of Hb
and Hb/DDDA decreased significantly after steam sterilization, and there was only 15-20%
specific activity retained after steam sterilization. As for Hb-DDDA, there was more than
80% specific activity retained.
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Figure 3.25
Photographs of Hb, Hb/DDDA, and Hb-DDDA solutions before and after steam
sterilization. The solutions were prepared by dissolving Hb, Hb/DDDA, and Hb-DDDA in
50 mM phosphate buffer (pH 8.0). after steam sterilization, the solutions were centrifuged
at 10k rpm for 10 minutes before the photographs were taken.
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Figure 3.26
The absorbance spectra of Hb, Hb/DDDA, and Hb-DDDA before and after steam
sterilization at 121 oC and cooling at room temperature for 30 minutes. The solutions were
in 50 mM phosphate buffer, pH 8.0.

Table 3.6
The summary of absorbance spectroscopy data of Hb, Hb/DDDA, and Hb-DDDA before
and after steam sterilization.
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Figure 3.27
The CD curves of Hb, Hb/DDDA, and Hb-DDDA before and after steam sterilization at
121 oC and cooling at room temperature for 30 minutes. The solutions were in 50 mM
phosphate buffer, pH 8.0.

Table 3.7
The summary of CD data of Hb, Hb/DDDA, and Hb-DDDA before and after steam
sterilization.
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Figure 3.28
(a) Peroxidase-like activities of unmodified hemoglobin, the physical mixture Hb/DDDA,
and Hb-DDDA before and after steam sterilization and cooling at room temperature.
Activities were measured with 0.5 mM H2O2 and 2.5 mM guaiacol in 50 mM phosphate
buffer (pH 8.0) at room temperature, with 1 µM protein presenting in the solution. (b)
Specific activity retention of unmodified hemoglobin, Hb/DDDA, and Hb-DDDA calculated
from the kinetic curves. The retention was determined by dividing the original specific
activity by that after steam sterilization and cooling process.
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3.4.18 Thermal stability studies at lower concentrations
The thermal stability studies discussed in the previous section were carried out
with 50 µM protein solution. After heating, there was a notable amount of precipitate in
Hb and Hb/DDDA solution. When the protein solution concentration is relatively high, the
denaturation by high temperature will induce the aggregation of protein molecules and
cause the precipitation. Due to the precipitation, the loss in the secondary structure,
absorbance intensity, and specific activity is caused by the denaturation of the protein I
the solution, as well as the lower amount of protein presenting in the solution. To study
about the thermal stability of the protein in the solution and remove the effect of
precipitation, the same thermal stability studies were carried out with lower concentrations
of protein presenting in the solution.
Four concentrations were tested, and the photographs of the protein solutions
before and after stem sterilization and centrifugation are shown in Figure 3.29. For all
four concentrations tested, Hb-DDDA didn’t show any precipitate after steam sterilizations.
When the concentration of protein was 50, 30, and 10 µM, there was precipitate after
steam sterilization for Hb and Hb/DDDA. When the concentration was 5 µM, no precipitate
was formed for all three samples, and this concentration was used to test the absorbance
spectroscopy and specific activity.
The absorbance spectra were taken, and the specific activity was tested (Figure
3.30). After steam sterilization, similar to the data gotten with higher concentration
solutions, the peak position of unmodified hemoglobin and the physical mixture Hb/DDDA
shifted from 406 nm to 408 nm, while that of the chemical conjugate Hb-DDDA remained
at 412 nm. The peak intensity retention was also calculated. After steam sterilization, both
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unmodified hemoglobin and the physical mixture Hb/DDDA lost about 50% absorbance
intensity, while the chemical conjugate Hb-DDDA remained more than 90% intensity. In
the specific activity study, after stem sterilization, Hb and Hb/DDDA lost more than 70%
specific activity compared to that before steam sterilization. Hb-DDDA remained more
than 90% of its activity. The data is summarized in Table 3.8. According to these
observations, we conclude that the loss of the absorbance, secondary structure, and the
peroxidase-like activity is not only due to the precipitation, but also the denaturation of the
protein in the solution. The conjugation of fatty acids not only protects the protein from
aggregation and precipitation, but also prevents the denaturation induced by high
temperature.
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Figure 3.29
Photographs of Hb, Hb/DDDA, and Hb-DDDA solutions at different concentrations before
and after steam sterilization. Four different concentrations were tested as 50 µM, 30 µM,
10 µM, and 5 µM. All the solutions were prepared with 50 mM phosphate buffer, pH 8.0.
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Figure 3.30
The absorbance spectra (a) and peroxidase-like activity studies (b) of Hb, Hb/DDDA, and
Hb-DDDA before and after steam sterilization. 5 µM protein solutions were steam
sterilized at 121 oC with 17 psi for 5 minutes and cooled at room temperature for 30
minutes. All the samples were centrifuged before the testes.

Table 3.8
The summary of the thermal stability studies by steam sterilization with low concentration
of protein presenting in the solution. 5 µM protein solutions were steam sterilized at 121
oC

for 5 minutes. The absorbance spectra were taken, and the specific activities were

tested.
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3.5 Conclusions
Here we reported a robust and efficient protocol to prepare water-soluble single
protein nanoparticles that are synthesized efficiently by coupling one of the COOH groups
a fatty diacid with the amine function of lysines on bovine serum albumin by carbodiimide
coupling. The stoichiometry among protein, fatty acid, and EDC was optimized to
generate the highest yield. After purification, the sizes and morphologies of particles were
characterized with DLS and TEM. By changing the fatty acids used, five single protein
nanoparticles with well-defined sizes and molecular compositions, without perturbation of
the protein structure, are reported for the first time. After modification, all different kinds
of nanoparticles fully retained the secondary structure from the protein. After labeled with
different fluorophores, these nanoparticles emit different colors without any changes on
the size, which is a unique advantage over the most commonly used quantum dots.
The thermal stability of the FluoDot is strongly dependent on the carbon chain
length of the fatty acids used. With longer carbon chains attached, the protein gets better
thermal stability. The lipid shell around the protein protects it from denaturation and
promotes efficient renaturation with shape-memory-like properties in a single particle,
which is unique. Longer chains help this recovery to a better degree.
The particles are labeled with multiple chromophores in one step to generate
white-emitting SNPs, for the first time. The emission colors only depend on the dyes used
to label the protein and are independent from the size of the protein nanoparticles. The
ratio between the chromophores and proteins can be optimized to the desired number by
changing the initial concentrations during the synthesis. As a result, the brightness of
each particle can be controlled and optimized.
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Long time storage stability was also improved by the fatty diacid conjugation. The
shelf half-life of FluoDot24 is 710 days, which is more than 5 times longer than unmodified
protein at room temperature.
This is a modular method to synthesize single protein nanoparticles with improved
the thermal stability. Hemoglobin was used to test the method as well. After fatty diacid
conjugation, the biological activities of the protein are retained which is advantageous for
certain applications. With a certain degree of loss, the absorbance, secondary structure,
redox activity, and peroxidase-like activity were retained after the reaction. The thermal
stability of hemoglobin was significantly improved with the lipid shell attached.
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Chapter 4 Edible Hydrogels from Bovine Serum Albumin and Medium Chain Fatty
Acids for Light-harvesting Devices and White-light Emitters
4.1 Abstract
With the goal of producing solar energy conversion devices that are
environmentally friendly, green and sustainable, we are designing and evaluating artificial
light antenna systems using biological soft materials.

For example, well-controlled

stoichiometric mixtures of four different dyes, bovine serum albumin and medium chain
fatty acids form soft hydrogels when the mixtures are heated at 121 oC for 15 minutes.
These gels contain roughly 90% water and they are transparent to the eye when the dyes
are absent. This is a robust and facile strategy to prepare biocompatible hydrogels
composed of a protein, dyes and fatty acids which are digestible, in principle. The gelation
was triggered by the weak physical interactions between partially unfolded protein and
the fatty acid but unperturbed by the presence of added dye molecules or the type of dye
molecules used. We postulate that the dyes are embedded in these hydrogels at discrete
binding sites as monomeric entities and their concentrations are adjusted for efficient
energy transfer from the highest energy donor to the lower energy acceptors. Thus, an
energy transfer cascade system among four different singlet energy states are
constructed, and excitation of any of the dyes results in intense emission from the lowest
energy acceptor state as visualized in the figure below.

The transparent and

mechanically strong hydrogels could be simply prepared by annealing their physical
mixtures. The resulting hydrogels with a shear thin-recovery behavior were syringeinjectable for device or biomedical applications. These gels may also be suitable for
implantable scaffolds for the long-term release of drug molecules in vivo, where the dyes
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are replaced by drug molecules, or they may function as light-harvesting complexes when
loaded with appropriate donor and acceptor dye molecules.
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4.2 Introduction
Solar energy is a long-term and sustainable energy source.1 Solar cell panels were
applied more and more widely to efficiently use the solar energy. Different systems have
been tried to prepare light-harvesting devices.2–4 However, these systems still have the
fundamental challenge to be applied for solar cell applications.5 For example, the solutionbased systems are not suitable to be used as coating materials. Moreover, their stability
is also critical for applications. Most solar cells have poor efficiency in the blue region,
and the efficiency of solar cells can be increased by more extensive usage of blue photons
in the solar energy.6 Conversion of blue photons to the longer wavelength photons is one
of useful strategies to improve overall cell performance and longevity. Therefore, a lightharvesting device that converts blue photons to red photons and operates in the solid
phase would be attractive.7
Recently, the synthesis of white light emitter materials attracts more and more
attention. White light is consisted of three primary colors, red, green and blue. When these
three colors have the equal emittance in the system, the white light can be generated.
White light emitter has potential applications, and especially important as new solid-state
lighting sources.
There are two main approaches to synthesize the white light emitters. The first one
is based on the inorganic materials. This kind of white light phosphors always depends
on metal complexes, such as Al3+, Zn2+, Ce3+, Eu3+, etc,8–11 or inorganic complexes, such
as sulfide, nitride, silicate, etc.12–14 These inorganic materials have their disadvantages,
such as harsh experimental conditions for synthesis including extremely high
temperatures,15 and hazard chemicals used.16 in addition, these preparation methods
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need complicated technologies that are not suitable for industrial fabrication. Moreover,
short lives and toxicity of these materials restrict their application in the daily life.
Another category to prepare white light emitter is based on the organic materials.
The organic white light emitters are always consisted of three individual colors in multiple
layers. Polymers and synthesized organic compounds are always used to emit different
colors. To generate white light emitter, these organic molecules are loaded in multiple
layers to perform efficiently.17 However, artificially synthesized organic compounds are
always not environmentally friendly. In addition, most organic white light emitting
materials are limited in solution phase, which is a big problem when they are used as
coating materials for LEDs.
Recently, more and more biomaterials have been used as white light emitters.
However, these materials are always used with inorganic or organic materials. For
example, a bio-hybridized polymer material was synthesized and salmon-DNA was
chosen as An electron-blocking layer to combine with three different polymer molecules
to be used as white light emitting diode.18 The silk proteins were also used with a series
of quantum dots to fabricate white light emitters.19 These cases overcame some of the
problems we are facing in a certain degree. However, these materials are still using the
complexes which are nondegradable or toxic at varying degrees. There is still a big
challenge to generate a low-cost, easy-synthesis, biodegradable and non-toxic white light
phosphors.
Here we used protein/lipid hydrogel as a platform to be used as light-harvesting
devices and white light emitter. Bovine serum albumin (BSA) was chosen due to its large
abundant and relative stability. Decanoic acid (C10) was used as the lipid to protect
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protein from denaturation. Free-standing protein/lipid hydrogels were prepared by heating
at 121 oC in the autoclave due to thermal-induced co-assembly. By simply dissolving the
fluorescent dyes in BSA/C10 solution prior to gelation, efficient foster resonance energy
transfer (FRET) and white light were generated. The concentrations of fluorescent dyes
are adjusted. For FRET application, the excitation of the donor at 350 nm results in an
intense red emission at 590 nm (Scheme 4.1). To generate white light emitter, with the
excitation at 365 nm, a bright white color was generated and can be observed by naked
eye. This is a robust, facile, and simple strategy with easy chemistry under mild reaction
conditions to prepare biocompatible, biodegradable, non-toxic, and environmentally and
economically friendly hydrogels for optical applications.
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Scheme 4.1
The physical mixture of BSA, decanoic acid, and chromophores was heated to form the
transparent gel. The ratio and composition of four dyes were optimized for the highest
efficiency of FRET.
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4.3 Experimental
4.3.1 Materials
Bovine serum albumin (BSA) was purchased from Equitech-Bio, Inc (Texas).
Decanoic acid, sodium hydroxide, hoechst 33258, and fluorescein were purchased from
Sigma Aldrich (Milwaukee, WI). Coumarin 540A (C) was purchased from Exciton
Chemical Co. Inc., (Ohio). Rhodamine B was purchased from Eastman Kodak Company
(Rochester, NY).
4.3.2 Synthesis of BSA/C10 hydrogel
The stock solution of decanoic acid (C10) was prepared by dissolving 400 mM
decanoic acid in DI water with enough sodium hydroxide. The stock solution of BSA was
prepared by dissolving 200 mg/mL (~ 3 mM) BSA in DI water. Different compositions were
used to prepare BSA/C10 hydrogel. The concentration of BSA in the final solution was
kept as 100 mg/mL, and the concentration of C10 was varied from 1 to 100 mM. BSA
solution and C10 solution were mixed, and the mixture solution was then heated in a 90
oC

oil bath or autoclave until gelation. Gelation was confirmed by the inversion test.

4.3.3 Scanning electron microscopy (SEM)
Scanning electron microscopy images were run on a Teneo LVSEM. BSA thermal
hydrogel and BSA/C10 hydrogel were sliced with a razor blade and put into centrifuge
tubes. The centrifuge tubes were punctured with a needle and dipped in liquid nitrogen
before freeze drying overnight. Once freeze dried the samples were further sliced and
affixed to the SEM stub using carbon tape. Samples were taken for Au/Pd spin-coating
(5 nm, 80% Au, 20% Pd) the next day and imaged immediately afterwards.
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4.3.4 Binding studies of dyes with BSA
The binding constant of rhodamine B (RhB), fluorescein (F), coumarin 540A
(C540A), and Hoechst 33258 (H) to BSA were determined by fluorescence polarization
anisotropy (FPA). Briefly, a series of solutions containing 10 µM fluorescent dye and
different concentrations of BSA (1-128 µM) was prepared in DI water and equilibrated for
at least an hour. Fluorescence anisotropy was measured with a Molecular Devices
FlexStation 3 Microplate Reader. The PMT sensitivity was set as low, and auto cutoff filter
was used for the measurements. For RhB, λexcitation = 554 nm, λemission = 582 nm; for F,
λexcitation = 484 nm, λemission = 513 nm; for C540A, λexcitation = 420 nm, λemission = 556 nm;
and for H, λexcitation = 350 nm, λemission = 460 nm. A simple equilibrium model was used to
obtain the dissociation constant (Kd) from the data, and Kaleidagraph was used for nonlinear curve fitting according to the following equation:
𝑟𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 = 𝑟𝐹 + (𝑟𝐵 − 𝑟𝐹 )

[𝐵𝑆𝐴] 𝑇
𝐾𝑑 + [𝐵𝑆𝐴] 𝑇

where r indicates the anisotropy, subscripts F and B indicate free and bound states, K d
indicates the dissociation constant, and [BSA]T indicates the total concentration of BSA.
4.3.5 Synthesis of artificial antenna system
The artificial antenna system was obtained by adding Coumarin 540A (C540A,
blue), Hoechst 33258 (H), fluorescein (F, green), and rhodamine B (RhB, red) to the
solution before gel forms. DI water was used to prepare the stock solutions of RhB (10
mM), F (10 mM), and H (5 mM), and dimethylformamide (DMF) was used to prepared
C540A stock solution (25 mM). Four dyes were added into the mixture solution of BSA
and decanoic acid. The mixture solution with four dyes was then heated to for the hydrogel
as described above.
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4.3.6 Absorbance and fluorescence measurements
Absorbance spectra of the hydrogels on glass cover slips were collected using HP
8453 diode array spectrophotometer from Agilent Technologies (Mendon, MA). Steady
state fluorescence spectra were collected with a fluorescence spectrometer or Molecular
Devices FlexStation 3 Microplate Reader. With a fluorescence spectrometer, the front
phase accessory and slit widths set to 2.5 mm were used to collect emission and
excitation spectra of the hydrogels. During the measurements, glass cover slips were
oriented, and the samples were moved around and rotated to check for uniformity, and
several vertical orientations at fixed incidence angle were used to obtain the averaged
values.
4.3.7 Dynamic light scattering (DLS)
Hydrodynamic size of BSA, decanoic acid micelles, and BSA/C10 complex were
monitored by means of photon correlation spectroscopy with Precision Detectors (Varian
Inc.), CoolBatch+ dynamic light scattering apparatus with 10 × 10 mm 2 cuvette, 658 nm
excitation laser source with a 90° geometry. Data collection was done at room
temperature, 1 s response, 3 repetitions, and 100 accumulations. BSA and the FluoDot
nanoparticles were dissolved in 50 mM phosphate buffer, and the solutions were filtered
with 0.22 μm filters (polyvinylidene diﬂuoride, PVDF, 13 mm, Restek) before the
measurements. Precision Ellucidate v 1.1.0.9 and Precision Deconvolve v 5.5 were used
to collect and analyze the data, respectively.
4.3.8 Circular dichroism (CD)
The retention of the secondary structure was tested by circular dichroism (CD). CD
spectra were got from Jasco J-710 spectropolarimeter. There were around 0.3 μM protein
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dissolved in 50 mM phosphate buffer (pH 8.0) in the samples used for measurements.
Spectra were obtained using a 0.05 cm path length quartz cuvette from 260 nm to 190
nm. The sensitivity was set as100 mdeg and the data pitch as 0.5 nm, with continuous
scanning mode, 50 nm min-1 scanning speed, 1 s response, 1.0 nm bandwidth, and three
accumulations. The baseline was measured with 50 mM phosphate buffer (pH 8.0) and
subtracted from each spectrum.
4.3.9 Agarose gel electrophoresis
0.5% agarose gel was prepared. 125 mg agarose was dissolved in 25 mL trisacetate buffer (40 mM, pH 7.0) by microwaving for 1 minute. The agarose solution was
then poured and stand for 30 minutes at room temperature. Samples were prepared by
mixing 10 μL protein solution (1 mg/mL) with 10 μL of agarose loading buffer (50% v/v
glycerol solution containing 0.01% m/v bromophenol blue). 15 μL of each sample was
then loaded in each well (7.5 μg of protein/well). The agarose gel was run at 100 mV for
25 minutes with Gibco BRL Model 200 power supplier. After running, the agarose gel was
stained with 20% v/v acetic acid solution containing 0.003% m/v brilliant blue R-250, and
destained with 10% v/v acetic acid solution.
4.3.10 Polyacrylamide gel electrophoresis (SDS-PAGE)
The gel contains separating gel (7.5%) on the bottom and stacking gel on the top.
The samples were prepared by mixing 10 μL of protein solution (1 mg/mL) with 10 μL
loading buffer (2% SDS, 10% beta-mercaptoethanol, BME), and heated in 80 oC water
bath for 5 minutes. 15 μL of each sample was then loaded in each well (7.5 μg of
protein/well). The gel was run at 200 mV for 30 minutes with Bio-Rad Mini Protean
Electrophoresis apparatus. After running, the gel was stained with stain I (10% v/v acetic
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acid, 10% v/v isopropanol, 0.003% m/v brilliant blue R-250) and stain II (20% v/v acetic
acid, 0.003% m/v brilliant blue R-250), and destained with 10% v/v acetic acid solution.
4.3.11 Synthesis of white-light emitter
White light emission was obtained by adding anthracene (A, blue), fluorescein (F,
green), and rhodamine B (RhB, red) to the gel matrix. The incorporation of the dyes was
tested both before and after the gelation. [BSA] = 100 mg/mL (~1.5 mM), [RhB] = 0.058
mM, [F] = 0.075 mM, and [A] = 0.75 mM. White emission was obtained by systematically
varying dye concentrations and validated using CIE 1931 chromaticity coordinates.
Chromaticity coordinates were calculated using MatLab 2013A and the open source “CIE
Coordinate Calculator” by Prashant Patil.
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4.4 Results and discussion
4.4.1 Synthesis of BSA/C10 hydrogel
Here we designed a novel kind of platform for optical applications, including FRET
light-harvesting devices and white light emitters. This hydrogel is composed of protein,
medium-long chain fatty acid, and organic dyes. We chose bovine serum albumin (BSA)
and decanoic acid (C10) which are biodegradable and non-toxic. The physical mixture of
BSA and decanoic acid was heated to form the transparent and soft gel. It’s an easy
synthesis procedure by just annealing the physical mixture for about 20 minutes. As the
hydrogel contains about 90% water so it’s soft and syringe-injectable and hence, can be
applied in shape.
The concentration of C10 was tested by preparing a series of hydrogels with
different concentrations of C10. The critical micelle concertation (CMC) of C10 was
reported as 50 mM, and 5 different concentrations were tested here, as 0, 20, 50, 80, and
100 mM. After heating at 121 oC in autoclave, the samples with higher concentrations of
C10 showed the formation of transparent hydrogels (Figure 4.1). SEM was then used to
investigate the morphology of these hydrogels (Figure 4.2). Without C10, thermal treated
BSA hydrogel showed the honeycomb structure. With C10 that the concentration is lower
than CMC, the hydrogel showed porous structure with clear edges. When the
concentration of C10 was higher than CMC, the hydrogel showed the walls of pores as
fibers, with deep porous.
The release of BSA was also studied to determine the free protein amount in the
hydrogel. Briefly, 300 µL hydrogel was put in 2 mL DI water. 5 µL of the solution was
collected at different time intervals. The concentration of protein in the solution was
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determined by Bradford assay. The percentage of retained protein was calculated by
dividing the total protein amount by the protein retained in the hydrogel and plotted versus
the time length (Figure 4.3). With higher concentration of C10, there was more free
protein stored in the hydrogel without crosslinking. When there was no C10 presenting in
the hydrogel, all the protein was used to form the hydrogel network and stored in the
hydrogel.
The gels were loaded with four specific dyes as a series to produce efficient Förster
resonance energy transfer (FRET). Here we chose rhodamine B, fluorescein, coumarin
540A, and Hoechst 55328 as the donors and acceptors (Figure 4.4). We postulate that
the dyes are embedded in these hydrogels at discrete binding sites, so the gelation was
unperturbed by the presence of added dyes. After mixed with four dyes, the gel shows
pink-orange color under the room light, while shows bright red fluorescence under the UV
light. All the materials used in this procedure are nontoxic, digestible, biocompatible and
biodegradable. This is a novel, robust and facile strategy to prepare white light emission
biological hydrogel.
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Figure 4.1
Photographs of BSA with different concentrations of C10 heated in autoclave at 121 oC
for (a) 25 minutes and (b) 15 minutes. From left to right, the concentration of C10 was
adjusted to 0, 20, 50, 80, and 100 mM. The insert in (a) show the reversion test to confirm
gelation.

Figure 4.2
SEM images of BSA/OA hydrogels with different concentrations of C10. (a) 100 mg/mL
BSA with 0 mM C10. (b) 100 mg/mL BSA with 40 mM C10, which is lower than the critical
micelle concentration of C10. (c) 100 mg/mL BSA with 100 mM C10, which is higher than
the critical micelle concentration of C10.
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Figure 4.3
Protein leaking studies of BSA/C10 hydrogels with different concentrations of C10. The
concentrations of BSA was kept as 100 mg/mL, and the concentration of C10 was varied
from 0 to 100 mM. 300 µL of each hydrogel were stored in 2 mL DI water. The amount of
leaked protein was determined by the concentrations of protein in the supernatant by
Bradford assay.

Figure 4.4
Chemical structures of (a) Hoechst 33258, (b) coumarin 540A, (c) fluorescein, and (d)
rhodamine B.
143

4.4.2 Binding studies of fluorescent dyes to BSA
The binding properties of each fluorescent dye to BSA were characterized with
fluorescence polarization anisotropy. Briefly, 10 µM of each fluorescent dye was mixed
with different concentrations of BSA. The fluorescence polarization anisotropy was
measured, and a non-linear regression was used to determine the dissociation constant
(Figure 4.5).
The dissociation constant of rhodamine B to BSA was determined as 76 µM, and
the binding constant was calculated as 1.3 × 104 M-1. For fluorescein, the dissociation
constant was determined as 7 µM, and the binding constant was calculated as 1.4 × 105
M-1. For coumarin 540A, the dissociation constant was determined as 4 µM, and the
binding constant was calculated as 2.5 × 105 M-1. For Hoechst 33258, the dissociation
constant was determined as 9 µM, and the binding constant was calculated as 1.1 × 105
M-1.
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Figure 4.5
Fluorescence polarization anisotropy of each fluorescent dye with BSA, as (a) Rhodamine
B, (b) fluorescein, (c) coumarin 540A, and (d) Hoechst 55328. The concentration of each
dye was kept as 10 µM, and the concentration of BSA was varied from 1 t0 128 µM. The
dissociation constants were calculated as m1 in each graph.
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4.4.3 Characterizations of BSA/C10 hydrogel
Decanoic acid (C10) was dissolved in DI water with enough NaOH. To obtain a
micelles solution, we used 100 mM in C10 solution which is much higher than the CMC.
100 mg/mL BSA solution in DI water showed the dynamic diameter at 3.6 nm, 100 mM
C10 solution has the dynamic diameter at 2.5 nm, and the physical mixture of BSA and
C10 micelles that was prepared by dissolving 100 mg/mL of BSA in 100 mM C10 solution
showed the dynamic diameter ay 6 nm (Figure 4.6). The dynamic light scattering (DLS)
result shows that, very likely, the BSA/C10 conjugate particle is composed of 1 protein
molecule and 1 C10 micelle. The conjugating happened after physically mixing BSA and
decanoic acid immediately. We postulate that, the formation of BSA/C10 conjugates is
because of the hydrophobic interaction between BSA and decanoic acid micelles.
After then, the mixture solution is heated at 90 oC for about 20 minutes to form the
gel. During the heating process, the solution became stickier and stickier, until formed the
whole-volume gel. As these gels contain about 90% water, they are transparent and soft,
and syringe injectable. The size of particles increased during the heating process. The
circular dichroism (CD) results showed that, at high temperature, both BSA and BSA/C10
physical mixture lost the secondary structure completely (Figure 4.7a). Part of lost
secondary structure in BSA folded back after cooling down to the room temperature, and
the CD of BSA in the hydrogel showed that, BSA retains most of the secondary structure
after gel formation (Figure 4.7b). These results demonstrate that, the decanoic acid
protects BSA from denaturation by high temperature.
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Figure 4.6
The DLS of (a) BSA, (b) C10, and the physical mixture of BSA and decanoic acid.

Figure 4.7
(a) The CD of BSA/C10 samples at 80℃. The temperature was equalized by keeping the
samples at 80 oC. (b) The CD of BSA/C10 hydrogel at room temperature. The hydrogel
sample was dissolved in 100 mg/mL SDS solution. The spectra of native BSA and
hydrogel sample were taken with the same concentration of BSA as 2.5 μM.
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4.4.4 Gel electrophoresis
The agarose gel of BSA/C10 heated for different times was run with 40 mM trisacetate buffer at pH 7 (Figure 4.8a). The gel was run under 100 mV for 30 minutes and
stained with Coomassie blue. The result shows that the physical mixture (Lane 2) doesn’t
show an obvious change compared with native BSA. During the heating process (Lane
3-8), the protein travels shorter than free native protein. In the Lane 7 and 8, smear bands
appeared. That means the size of the protein-lipid particles increases, and the size is not
uniform before the gelation.
The SDS-PAGE (Figure 4.8b) was run with unmodified BSA and gel sample
dissolved in 100 mg/mL SDS solution. The hydrogel can be dissolved in SDS solution,
which is also an evidence of the statement that the gelation is because of weak physical
attachment, rather than the chemical linking. The gel electrophoresis result shows that
while getting rid of the electronic affect, the molecular weight of BSA in the hydrogel (Lane
3) is around 66 kDa, which doesn’t change obviously compared with unmodified BSA
(Lane 2). This result indicates the gelation is not because of the denaturation or crosslinking of protein. This result further demonstrates that, the C10 acid plays an important
role of protecting BSA from denaturation by heating at high temperature. The existence
of C10 resists the cross-ling among BSA molecules.
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Figure 4.8
(a) The agarose gel was run with 40 mM tris-acetate buffer at pH 7. Lane 1: Native BSA;
lane 2: BSA/C10 mixture; lanes 3-8: BSA/C10 heated at 90oC for 3 min, 6 min, 9 min, 12
min, 15 min, and 18 min. (b) The SDS-PAGE of gel sample. Lane 1: Marker; Lane 2: BSA;
Lane 3: BSA/C10 hydrogel (the sample was prepared by dissolving the BSA/C10
hydrogel in 100 mg/mL SDS solution)
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This hydrogel is highly stable under the room temperature. When it’s immersed in
a large amount of water, the gel begins to swell without falling apart. Moreover, the gel is
stable in different pHs (from 1 to 10) of sodium phosphate solution for several days. The
gel begins to dissolve at pH 10 after stay for 3 days. That is because the high pH solution
denatured most of BSA which is required by gelation. The results showed above prove
that the BSA/C10 hydrogel can be synthesized via an easy and facile strategy, which is
just annealing the physical mixture. This strategy doesn’t harm the secondary structure
of the protein, and the presence of decanoic acid stabilizes the protein remarkably. The
resulting hydrogel has a relatively mechanically strong structure and syring-injectivity,
which are suitable for the potential application as the coating materials on solar cell panels
as light-harvesting devices, or on the LEDs to emit white light.
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4.4.5 The effects of BSA and C10 to the optical properties of dyes
The optical properties of fluorescent dyes were studied with and without the
presence of BSA and C10. For each dye, the absorbance and emission spectra were
recorded as the single dye in aqueous solution, with the presence of BSA, and with the
presence of both BSA and C10 (Figure 4.9). We chose Hoechst, coumarin 540A,
fluorescein, and rhodamine B as FRET donors and acceptors. As these dyes have
specific sites on the BSA molecule, the gelation unperturbed by the presence of added
dyes.
The absorbance of Hoechst didn’t change by the addition of BSA or C10. Hoechst
absorbs at 345 nm. For coumarin 540A, the absorbance spectra changed. The maximum
peak shifted to a longer wavelength with the presence of BSA, and the extinction
coefficient decreased. With the addition of both BSA and C10, the maximum absorbance
peak stayed at the same position compared to that with the presence of only BSA, and
the extinction coefficient increased to about the same number with the original value. For
fluorescein, the aqueous solution showed double peaks in the range of 400-500 nm. With
the presence of BSA, the double peaks changed to one single peak, with the maximum
absorbance peak shifted to a longer wavelength, and the extinction coefficient increased.
With the presence of both BSA and C10, the maximum peak position shifted furthermore
to a longer wavelength with a higher extinction coefficient. For rhodamine B, the
absorbance peak didn’t shift the position, but with a slightly higher extinction coefficient.
For the emission spectra, the emission of the dyes also changed according to the
addition of BSA or both BSA and C10. For Hoechst, it emits at 500 nm without any BSA
or C10. With the presence of BSA, the emission peak shifted to 450 nm with a lower
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intensity. With the addition of both BSA and C10, the emission peak was at 450 nm, with
an even lower fluorescence intensity. For coumarin 540A, it emits at 550 nm in aqueous
solution. With the presence of BSA, the emission shifted to 520 nm, with a higher intensity.
Coumarin 540A is hydrophobic, and the fluorescence is quenched when exposed into
aqueous environment. With the presence of BSA, coumarin bound to the hydrophobic
binding site of BSA, and fluorescence intensity was enhanced. With the presence of both
BSA and C10, the emission peak stayed at the same position, with a lower emission
intensity, which is possibly due to the competition binding of C10 and coumarin to BSA.
For fluorescein, the emission peak shifted to longer wavelength with a slightly lower
intensity with the presence of BSA. With the presence of both BSA and C10, the emission
intensity increased dramatically, due to the addition of C10. For rhodamine B, the
emission peak position as well as the intensity didn’t change due to the addition of BSA
or both BSA and C10.
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Figure 4.9
(a) Absorbance spectra and (b) emission spectra of each fluorescence dye in aqueous
solution and with the presence of BSA or both BSA and C10. In all the samples containing
Hoechst, coumarin 540A, and fluorescein, [H] = 12.5 µM, [C540A] = 25 µM, [F] = 10 µM,
[BSA] = 5 mg/mL, and [C10] = 5 mM. in the samples containing rhodamine B, [RhB] = 20
µM, [BSA] = 1.25 mg/mL, and [C10] = 1.25 mM. For the emission spectra measurements,
λexcitation was 554 nm for RhB, 484 nm for fluorescein, 420 nm for C540A, and 350 nm for
Hoechst.
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4.4.6 Leaking studies of fluorescent dyes from BSA/C10 hydrogels
The leaking rate and percentage for each fluorescent dye from BSA/C10 hydrogels
were also studies. Briefly, 300 µL of BSA/C10 hydrogel incorporated with 0.25 mM H, 0.5
mM C, 0.2 mM F, or 1.6 mM RhB was put in 10 mL DI water. 200 µL of the solution were
taken at different time intervals. The concentration of each fluorescent dye in the solution
was determined by absorbance spectroscopy and the standard curved obtained (Figure
4.10). The percentage of the fluorescent dye that retained in the hydrogel was calculated
by dividing the original amount by the retained amount and plotted versus time (Figure
4.11).
As the leaking of fluorescent dyes happened at the same time with that of BSA,
the leaking rate and percentage of H were not able to be determined due to the
absorbance of BSA at 345 nm. There was no obvious peak at 345 nm, and it’s reasonable
to predict there was not notable amount of H leaking from the hydrogel.
The leaking of C540A was studied in the same way. After about 20 hours, the
amount of retained C540A reached plateau and stayed at about 70%. For RhB, the
retained amount reached plateau and stayed at about 10%. And for fluorescein, all the
dyes leaked out after about 7 hours.

154

Figure 4.10
The absorbance spectra of (a) rhodamine B, (c) fluorescein, (e) coumarin 540A, and (g)
Hoechst in different concentrations. The maximum absorbance peak intensity was then
plotted versus the concentration of the dye to obtain the standard curves of (b) rhodamine
B, (d) fluorescein, (f) coumarin 540A, and (h) Hoechst.
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Figure 4.11
The leaking studies of fluorescent dyes from BSA/C10 hydrogels.
155

4.4.7 Quenching studies in solution phase
Quenching studies were used to optimize the composition of H, C540A, F, and
RhB to achieve efficient FRET. The quenching studies were conducted in solution phase
with only BSA and with the presence of both BSA and C10 (Figure 4.12).
Firstly, the quenching of H emission by C540A was tested (Figure 4.12a, d). The
concentration of H was kept constant at 0.25 mM, and the concentration of C540A was
varied from 0 to 5 mM. The concentration of BSA was kept at 100 mg/mL, and the
concentration of C10 was either 0 or 100 mM. With as low as 0.5 mM C540A, all the
emission from H was transferred completely for both BSA solution and BSA/C10 solution.
After then 0.25 mM H and 0.5 mM C540A were used to test the quenching of
emission from H and C540A by F (Figure 4.12b, e). The concentration of F was varied
from 0 to 2 mM. In only BSA solution, the quenching was completed when the
concentration of F was 2 mM. For BSA/C10 solution, the emission from both H and C540A
was quenched completely with 0.2 mM F.
To test the quenching by the last dye, 0.25 mM H, 0.5 mM C540A, and 0.2 mM F
were used, and the concentration of RhB was varied from 0 to 1.6 mM (Figure 4.12c, f).
In only BSA solution, the emission from H, C540A, and F was transferred nearly
completely with 0.8 mM RhB. The quenching study was also carried out in BSA/C10
solution. With 0.9-1.6 mM RhB, the emission from H, C540A, and F was quenched
completely.
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Figure 4.12
Quenching studies of H emission by C540A (a and d), H and C540A emission by F (b
and e), and H, C540A, and F emission by RhB. The quenching studies were done in
solution phase with the presence of 100/mL BSA (a-c), and with the presence of 100
mg/mL BSA and 100 mM C10 (d-f).
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4.4.8 FRET in solution phase
FRET was tested in solution phase with the optimized concentrations of H, C540A,
F, and RhB. The concentration of BSA was kept as 100 mg/mL, and the concentration of
C10 was varied as 0, 20, 50, 80, and 100 mM. The emission and excitation spectra were
recorded (Figure 4.13).
The emission spectra are nearly identical disregarding of the concentration of C10.
The maximum emission was observed at 590 nm, which is from the emission of RhB. The
excitation spectra were also recorded by setting the emission wavelength at 590 nm. The
excitation spectra showed all excitation peaks from four fluorescent dyes.
The success of FRET was also confirmed by comparing the sum of BSA or
BSA/C10 solution with each single dye with the solution with all four fluorescent dyes
(Figure 4.14). Comparing the emission spectra, the summed curves showed the emission
peaks over the scanned range, while the FRET spectra showed only emission from RhB.
Comparing the excitation spectra, the summer curves showed the maximum excitation
peak at 550 nm, while the FRET spectra showed the excitation from all four fluorescent
dyes.
The solutions without the presence of one dye were also prepared in BSA/C10
solution. The excitation wavelength was set at 350 nm, and the emission was scanned
from 400 to 650 nm. Without RhB, the maximum emission was from F. Without F, there
was emission from H and RhB showing as two separate emission peaks. Without C540A,
there were three separate peaks showing the emission from H, F, and RhB. Without
C540A, the emission of F and RhB were at lower intensities as two separate peaks.
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Figure 4.13
(a) The emission spectra and (b) excitation spectra of FRET solution with different
concentrations C10. [BSA] = 1.5 mM, [H] = 0.25 mM, [C540A] = 0.5 mM, [F] = 0.2 mM,
and [RhB] = 1.6 mM. The emission spectra were recorded with the excitation wavelength
at 350 nm, and the emission was scanned from 400 to 650 nm. the excitation spectra
were recorded with setting the emission wavelength a5 590 nm, and the excitation was
scanned from 500 to 570 nm.
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Figure 4.14
Comparison between (a) emission spectra and (b) excitation spectra between the sum of
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Figure 4.15
The emission spectra of BSA/C10 solutions with 3 dyes presenting. [BSA] = 1.5 mM, [H]
= 0.25 mM, [C540A] = 0.5 mM, [F] = 0.2 mM, and [RhB] = 1.6 mM. The excitation
wavelength was set at 350 nm, and the emission was scanned from 400 to 650 nm,
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4.4.9 FRET in gel phase
FRET was then tested in hydrogel phase with the optimized concentrations of H,
C540A, F, and RhB. The concentration of BSA was kept as 100 mg/mL, and the
concentration of C10 was kept as 100 mM. The emission and excitation spectra of single
dye incorporated BSA/C10 hydrogel and FRET BSA/C10 hydrogel were recorded (Figure
4.16).
Comparing the sum of emission spectra of BSA/C10 hydrogels with each single
dye with that of FRET BSA/C10 hydrogel was used to confirm the success of FRET in gel
phase. Comparing the emission spectra, the summed curves showed the emission peaks
over the scanned range, while the FRET spectra showed only emission from RhB.
Comparing the excitation spectra, the summer curves showed the maximum excitation
peak at 550 nm, while the FRET spectra showed the excitation from all four fluorescent
dyes.
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Figure 4.16
(a) The emission spectra of single dye incorporated BSA/C10 hydrogels. (b) The
comparison between the sum of the spectra of single dye incorporated BSA/C10
hydrogels and that of FRET BSA/C10 hydrogel. (c) The excitation spectra of single dye
incorporated BSA/C10 hydrogels. (d) The comparison between the sum of the spectra of
single dye incorporated BSA/C10 hydrogels and that of FRET BSA/C10 hydrogel.
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4.4.10 White-emitting BSA/C10 hydrogels
We chose anthracene, fluorescein, and rhodamine B as the blue, green and red
dyes to generate white light. As these dyes have specific sites on the BSA molecule, the
gelation unperturbed by the presence of added dyes. The conjugates of BSA/C10
hydrogel with individual dyes and multiple dyes were characterized with UV-Vis and
fluorescence spectroscopy. With excitation wavelength of 365 nm, the ratio of BSA: R: F:
A was chosen as 180:7:9:90 to generate white light.
The absorbance spectrum BSA/C10 white light emitter was recorded, and
emission spectrum was recorded with the excitation at 365 nm (Figure 4.17a, b). The
absorbance spectrum showed three separate peaks corresponding to A, F, and RhB. The
emission spectrum was also recorded, and the emission peaks from three separate dyes
were observed. The chromaticity was calculated according to the emission spectrum as
0.3361, 0.3393.
The hydrogel contains about 90% of water so it’s soft and flexible. BSA/C10
hydrogel can be synthesized on a flexible film. The gel didn’t crack when it was bent. As
it’s syringe-injectable, it can be applied on the glass slide with a syringe and a needle to
be in the letter shape (Figure 4.17c). As the BSA/C10 hydrogel is soft, it’s a candidate
for coating material to be coated on the LEDs. The 365 nm UV LED shows dark UV blue
light without coating, while the coated one shows bright white light because of the
excitation of UV light. The photo stability of BSA/C10 white light emitter was tested with
LEDs (Figure 4.17d).
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Figure 4.17
(a) The absorbance spectrum of BSA/C10 white light emitter. (b) The emission spectrum
of BSA/C10 white light emitter with excitation at 365 nm. The inset showed the
chromaticity calculated from the emission spectrum as 0.336, 0.339. (c) The soft hydrogel
gel can be applied by syringe on a glass slide in shape. The letters showed pink color
under the room light, while emitted white light with the excitation of 365 nm wavelength
UV light. (d) The gel converts blue UV light to bright white fluorescence when it’s coated
on UV LED.
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4.5 Conclusions
Here we presented an easy and facile strategy to form protein/lipid hydrogel by
annealing the physical mixture of BSA and decanoic acid. The decanoic acid shows an
important role of protecting BSA from denaturation by high temperature. While the gel
was loaded with three different dyes with specific compositions, the hydrogel emits white
light with different excitation wavelengths. This bio-white light emitter shows considerable
thermal and photo stabilities. As the flexibility of the hydrogel, this novel white light emitter
is an ideal coating material on LEDs. This novel white light emitter has many advantages
such as low-cost, easy-synthesis, biodegradable, non-toxic, syringe-injectable, is an ideal
material that has a widely potential industrial application.
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Chapter 5 Self-healing Hydrogels by Thermal-induced Protein-lipid Co-assembly
for Air-tolerant Photon Upconversion
5.1 Abstract
To achieve air-tolerant and efficient low-power upconverting devices that are
environmentally and economically friendly, we are optimizing and evaluating a novel
matrix for triplet-triplet annihilation-based photon upconversion (TTA-UC) with biological
materials. Here we report the first example of a self-healing protein-lipid hydrogel,
incorporated with a chromophore pair, to overcome limitations of current upconversion
systems, such as poor water-solubility of chromophores, disturbance of oxygen
molecules, complicated and time-consuming preparation, etc. In our hydrogel system, the
chromophores are solubilized in a protein solution with lipid micelles, which are further
stabilized and buried in a 3-D protein network. The protein sol-gel transition is irreversible
and formed via thermal treatment. The gelation is attributed to weak physical interactions
among protein molecules with partial denaturation, allowing simple self-healing of the
hydrogel via contact between the damaged surfaces and applied heat. This is a robust,
facile, and simple strategy to prepare free-standing, moldable, biocompatible, and
biodegradable hydrogels, which contain about 65% water and are completely transparent.
The concentrations of chromophores are adjusted for efficient photon upconversion from
the donor, with a longer wavelength absorption band, to the acceptor, with a shorter
wavelength emission band. Thus, the excitation of the donor, with a commercial 532 nm
laser, results in an intense blue emission with a higher energy from the accepter, which
can be visualized by the naked eye. Furthermore, this protein hydrogel can be formed
interlocking with cellulose fiber on a piece of regular filter paper. This hydrogel has
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potential in solar cell coatings for increased efficiency as well as device display and
sensing applications.
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5.2 Introduction
Photon upconversion is a kind of anti-Stokes fluorescence. There are two
mechanisms that have known to cause photon upconversion, as lanthanide upconversion
and triplet-triplet annihilation (TTA). Compared to lanthanide upconversion, TTA-based
upconversion systems have their unique advantage as tunable excitation and emission
properties, which can be achieved by varying the choices of the sensitizer and annihilator
pair.1 In a complete TTA-UC process, the sensitizer is firstly excited by a low energy
excitation to its singlet excited state (1S*), which is followed by intersystem crossing to its
triplet state (3T*). The triplet energy is then transferred from the sensitizer to the
annihilator via triplet-triplet energy transfer (TTET). A large amount of annihilators at their
triplet state is generated by repeating the process described above. With two annihilators
at their triplet state, triplet-triplet annihilation happens to generate a high energy state,
followed by intersystem crossing and the emission (Scheme 5.1).2 The emission has a
higher energy and lower wavelength compared to the excitation.
TTA-based upconversion can be used widely is various applications. Due to the
unique properties of upconversion, it can be applied in bioimaging,3–6 biosensing,7,8
photodynamic therapy,9,10 lighting devices,11 color-display devices,12 solar cells,13–16
photocurrent generation,17 and photocatalysis.18–21 For practical application, TTA-UC
requires efficient upconversion in oxygen-containing environments. However, it is
confronted by two major problems, as limited solubility of hydrophobic sensitizer and
annihilator molecules, and the quenching of triplet states induced by oxygen.22
For most of the optical applications such as lighting and display devices and solar
cell applications, solid-state TTA-UC materials are more suitable compared to aqueous-

170

state materials. Current methods to prepare solid-state TTA-UC materials include codoping both sensitizer and annihilator into a polymer matrix or doping the sensitizer in an
emissive polymer matrix,23 the modifications on nanocrystalline ZrO2 films,24 and the
incorporation of the fluorophores in nanofibers and mats.25
Hydrogels are a kind of materials that are formed by polymer chains interactions, 26
including synthetic polymers and natural polymers, for example, proteins. Protein
hydrogels can form via annealing or chemical cross-linking to form non-covalent or
covalent bonds. Most of recent optical coating materials are facing a significant challenge
as the biodegradability. To solve for this problem, protein hydrogels are unique
candidates that could be used as a platform to incorporate different organic phosphorus,
with optimized numbers and ratios, to have desired emissions.
Currently reported methods to prepare upconversion hydrogels have their
disadvantages. For example, the upconversion hydrogels can be made by using a
polyacrylic acid (PAA) hydrogel to absorb upconversion emulsion solution. 27 However,
simple absorption would cause release of the chromophores. The choice of PAA hydrogel
as the platform also resulted in different upconversion behaviors at different temperatures.
The upconversion hydrogel was also made by incorporating the acceptor (sodium 9,10diphenylanthracene-2-sulfonate, DAPS) with gelatin and dissolving the donor (Pt (II)
octaethylporphyrin, PtOEP) in gelatin solution.28 The gel formed spontaneously after
cooling. However, there are also conspicuous disadvantages including the previous
modification of 9,10-diphenylanthracene (DPA), no suitability for high temperature
applications, for example, solar cells, as gelatin hydrogel melts, and time-consuming
synthesis.
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Here we reported a novel synthesis of upconversion hydrogel, which used protein
hydrogel as a platform to be used as air-tolerant and efficient low-power upconverting
devices. Bovine serum albumin (BSA) was chosen due to its large abundant and relative
stability. Oleic acid was used as the hydrophobic incorporator to solubilize the
upconversion acceptor-donor pair. Irreversible sol-gel transition was observed when the
solution of BSA and oleic acid was heated to 90 oC. Free-standing protein/lipid hydrogels
by thermal-induced co-assembly. These hydrogels are self-healing due to the physical
interactions among protein molecules. By simply dissolving the fluorophores in an
upconversion pair prior to gelation, air-tolerant upconversion achieved with PdOEP and
DPA. The concentrations of chromophores are adjusted for efficient photon upconversion
from the donor, with a longer wavelength absorption band, to the acceptor, with a shorter
wavelength emission band. Thus, the excitation of the donor, with a commercial 532 nm
laser, results in an intense blue emission with a higher energy from the accepter, which
can be visualized by the naked eye. Moreover, the hydrogel can be made to interlock with
cellulose fibers, for sensing applications (Scheme 5.2). This is a robust, facile, and simple
strategy with easy chemistry under mild reaction conditions to prepare biocompatible,
biodegradable, non-toxic, and environmentally and economically friendly upconversion
hydrogels. This is the first example of a self-healing protein-lipid hydrogel, incorporated
with a chromophores pair, to overcome limitations of current upconversion systems.
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Scheme 5.1
The mechanism of triplet-triplet annihilation upconversion. Briefly, the sensitizer is
excited to its singlet excited state (1S*), followed by intersystem crossing (ISC) to its triplet
state (3T*). The triplet energy is then transferred to the annihilator via triplet-triplet energy
transfer (TTET). With two annihilators at their triplet state, triplet-triplet annihilation
happens to generate a high energy state, followed by intersystem crossing and the
emission.
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Scheme 5.2
Facile synthesis under mild reactions conditions to generate transparent protein/lipid
hydrogel by thermal induced self-assembly. Air-tolerant upconversion was achieved in a
protein hydrogel matrix. The protein hydrogels have self-healing property due to the
physical interaction among protein molecules. Synthesized materials are biocompatible
and biodegradable matrix. This hydrogel gel can also be interlocked with common filter
paper to generate upconversion paper for potential sensing applications.
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5.3 Experimental
5.3.1 Materials
Bovine serum albumin (BSA) was purchased from Equitech-Bio, Inc (Texas). Oleic
acid, 9,10-Diphenylanthracene, palladium (II) octaethylporphyrin, and sodium hydroxide
were purchased from Sigma Aldrich (Milwaukee, WI).
5.3.2 Synthesis of protein thermal hydrogels
150 µL oleic acid was mixed with 180 µL ethanol. With stirring, 500 µL BSA solution
(200 mg/mL in DI water) was added slowly. 170 µL sodium hydroxide solution (2.5 M in
DI water) was then added slowly with stirring. The mixture was then centrifuged at 13.3k
rpm to remove any precipitate. The solution was then heated in an 80 oC water bath.
Gelation was confirmed by the inversion test.
5.3.3 Synthesis of upconversion hydrogels
9,10-Diphenylanthracene (DPA) stock solution was prepared by dissolving 80 mM
DPA in tetrahydrofuran (THF). Palladium (II) octaethylporphyrin (PdOEP) stock solution
was prepared by dissolving 3 mM PdOEP in THF. 250 µL of DPA stock solution or 330
µL of PdOEP stock solution were added to 1 mL oleic acid. The mixtures were then heated
in 80 oC water bath to evaporate THF and prepare 20 mM DPA in oleic acid or 1 mM
PdOEP in oleic acid. 150 µL oleic acid and/or DPA in oleic acid and/or PdOEP in oleic
acid were mixed with 180 µL ethanol to achieve desired concentrations. With stirring, 500
µL BSA solution (200 mg/mL in DI water) was added slowly. 170 µL sodium hydroxide
solution (2.5 M in DI water) was then added slowly with stirring. The mixture was then
centrifuged at 13.3k rpm to remove any precipitate. The solution was then heated in an
80 oC water bath. Gelation was confirmed by the inversion test.
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5.3.4 Scanning electron microscopy (SEM)
Scanning electron microscopy images were run on a Teneo LVSEM. BSA thermal
hydrogel and BSA/OA hydrogel were sliced with a razor blade and put into centrifuge
tubes. The centrifuge tubes were punctured with a needle and dipped in liquid nitrogen
before freeze drying overnight. Once freeze dried the samples were further sliced and
affixed to the SEM stub using carbon tape. Samples were taken for Au/Pd spin-coating
(5 nm, 80% Au, 20% Pd) the next day and imaged immediately afterwards.
5.3.5 Self-healing properties
BSA/OA hydrogels loaded with DPA and PdOEP were cut in half with a razor. Two
pieces were then pressed together and put back to the original container. Two broken
pieces were then heated in 80 oC water bath for 20 minutes. The self-healing of two
broken pieces to one gel was tested by hanging up. Forces were applied to the opposite
directions to test the resistance.
5.3.6 Fluorescence spectroscopy
Fluorescence emission and excitation spectra were obtained using a Molecular
Devices FlexStation 3 Microplate Reader. Gels were formed in the wells of a Greiner
CELLSTAR black polystyrene 96-well plate (100 µL solution). The spectra were gotten
immediately after the hydrogels formed. Emission spectra were collected with the
following parameters: 425 nm excitation, low photomultiplier tube (PMT) setting, six
readings per well, front-face detector.
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5.4 Results and discussion
5.4.1 Synthesis and characterization of BSA/OA hydrogel
Protein/oleic acid hydrogel was prepared by heating a mixture solution of bovine
serum albumin and oleic acid. The composition of oleic acid, ethanol, BSA, and sodium
hydroxide was optimized for the easiest preparation. Ethanol was used to increase the
mobility of the mixture solution, and sodium hydroxide was used to clear up the mixture
solution by neutralizing oleic acid. The concentration of BSA was kept necessarily high
for gelation. The optimized final concentrations were adjusted as 15% oleic acid, 18%
ethanol, 425 mM NaOH, and 100 mg/mL BSA.
Compared to the thermal hydrogel made with only BSA without oleic acid, BSA/OA
hydrogel was transparent while BSA hydrogel was opaque. Scanning electron
microscope was used to investigate the structures of these hydrogels. BSA thermal
hydrogel showed non-directed pores with sizes of 10-20 µm. The porous walls were not
connected. For BSA/OA hydrogel, the pore size is smaller than 10 µm, which is smaller
than the pore size of BSA thermal hydrogel. The edges of pores were flatter compared to
the porous wall of BSA thermal hydrogel. The pores are deeper than that of BSA thermal
hydrogel as well. Due to the differences between the structures of BSA and BSA/OA
hydrogels in pore size, pore shape, and pore edges morphology, BSA/OA hydrogel was
clear while BSA thermal hydrogel was opaque.
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Figure 5.1
Photographs and SEM images of BSA thermal hydrogel (c, d) and BSA/OA hydrogel (a,
b).
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5.4.2 Fourier transform infrared spectroscopy of BSA/OA hydrogel
The bonding changes in the hydrogel were studied with Fourier transform infrared
spectroscopy (FTIR, Figure 5.2). Compared to the FTIR spectrum of BSA powder, both
BSA hydrogel and BSA/OA hydrogel showed broader peak in the range of 3000-3500 cm1.

Moreover, comparing the frequency of the peak, the peak of the hydrogel (both BSA

and BSA/OA hydrogels) shifted to a lower frequency than BSA powder. This phenomenon
indicates the formation of hydrogel bond formation in the hydrogel. The peaks showing in
the range of 2800-300 cm-1 in the spectrum of BSA/OA hydrogel represented the
presence of oleic acid. Comparing the peaks in the range of 1400-1800 cm-1, amide I and
amide II peaks didn’t change the location for BSA powder and BSA thermal hydrogel. For
BSA/OA hydrogel, amide II peak which represents C=O stretching shifted to higher
frequency with a larger intensity. This peak represents both C=O bond from oleic acid
and BSA.
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Figure 5.2
FTIR spectra of BSA powder (black curve), BSA thermal hydrogel (green curve), and
BSA/OA hydrogel (red curve). The insert shows the zoomed in figure in the range of 10001800 cm-1.
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5.4.3 Synthesis of dye incorporated BSA/OA hydrogels
9,10-Diphenylanthracene (DPA) and palladium (II) octaethylporphyrin (PdOEP)
were chosen to act as upconversion donor-acceptor pair (Scheme 5.2). Similar to the
synthesis of BSA/OA thermal hydrogel, a mixture solution containing oleic acid, ethanol,
BSA, and sodium hydroxide was made, followed by the thermal treatment to prepare the
hydrogel.
Oleic acid was used to solubilize hydrophobic chromophores. Neither DPA nor
PdOEP solid is soluble in oleic acid. Tetrahydrofuran (THF) was used as the solvent to
dissolve both chromophores and to transfer the chromophores to oleic acid. Briefly, DPA
or PdOEP was dissolved in THF to prepare dye solutions. And then the dye solutions was
mixed with oleic acid. THF was evaporated by heating the mixture at 80 oC to prepare the
solution of DPA and PdOEP in oleic acid.
Similar preparation methods were then applied to prepare BSA/OA hydrogel with
dye incorporated. The dye solution in oleic acid was used to substitute oleic acid in the
preparation of the hydrogel.
5.4.4 Study of self-healing property
Different from other chemical linked hydrogels, thermal hydrogels are formed via
physical interactions. As a result, the physical interactions induced by thermal gelation
can be employed for self-healing purpose. The BSA/OA hydrogels loaded with DPA and
PdOEP were cut in half by a razor. By simply keeping the cut surfaces in contact at 80 C
for 15 min the mechanical damage in the hydrogel could be self-healed. When the gel
was pulled in opposite directions, the interface stayed healed.
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Scheme 5.3
The chemical structures of (a) DPA and (b) PdOEP.

Figure 5.3
Photographs of the hydrogels going through self-healing studies. BSA/OA hydrogels
loaded with DPA (yellow) and PdOEP (red) were cut in half with a razor. Two pieces were
then pressed together and put back to the original container. Two broken pieces were
then heated in 80 oC water bath for 20 minutes. Two pieces self-healed to one gel and
tested by hanging up. Forces were applied to the opposite directions, and the self-healing
gel can’t be pulled apart.
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5.4.5 Synthesis and characterization of upconversion hydrogels
The abosrbance spectra of PdOEP in a solution of oleic acid,ehtanol, and aqeous,
above solution mixed with BSA, and PdOEP in hydrogel gel phase were taken to observe
the differences in the optical properties of PdOEP (Figure 5.4). The absorbance psectra
showed that, when PdOEP was in solution phase, with or without the precense of BSA,
the maximum absorbance peak was at around 530 nm. When the gel phase formed, and
peak shifted slightly to the red region. In addition, the peak intensity was lower. Both the
changes in the peak position and peak intensity indicated the physical binding of PdOEP
in the hydrogel. The incorporation of PdOEP is not as simple as physical mixture, but with
physical interactions in the hydrogel. The retention of absorbnace peak position is
essential for upconversion. As the donor chromophore in upconversion process, the
retention of the abosrbance peak ensures the success of the excitaion with ab external
light source at a specific wavelength.
5.4.6 The effect of oleic acid to optical properties
The amount of oleic acid in the hydrogel was studied and optimized to have the
fluorescence intensity as high as possible. In this study, the concentration of DPA was
kept as 0, and only PdOEP was used to observe the fluorescence intensity. Briefly,
different amount of PdOEP in oleic acid was kept the same to achieve the same
concentration of PdOEP in the hydrogel, and the amount of oleic acid was adjusted to
have 1%, 8.5%, and 15% oleic acid. The fluorescence spectra of these hydrogels were
taken with the excitation at 532 nm, and the emission was scanned from 600 to 750 nm.
The emission peak of PdOEP is at around 665 nm. The peak intensity at 665 nm
was used to observe the effect of the amount of oleic acid in the optical properties of the

183

hydrogels. With 1% oleic acid presenting in the hydrogel, the fluorescence intensity at
665 nm was the lowest compared to the hydrogels with 8.5% and 15% oleic acid. With
8.5% oleic acid, the peak intensity increased dramatically compared to that when 1% oleic
acid presented.
With 15% oleic acid presenting in the hydrogel, the peak intensity increased
furthermore. Oleic acid is a fatty acid with 18 carbon atoms in the hydrocarbon chain.
When the concentration of oleic acid was high enough, the micelles formed to provide
hydrophobic environment for hydrophobic chromophores. When the concentration of
oleic acid increased furthermore, the amount of micelles increased more. With higher
amount of micelles, there were more chromophores solubilized in the micelles, which
result in the increase of emission peak intensity.

184

Figure 5.4
The absorbance spectra of PdOEP solution in oleic acid, ethanol, and aqueous solution
(blue), above solution mixed with BSA (green), and PdOEP in BSA/OA hydrogel phase
(red).

Figure 5.5
The fluorescence spectra of PdOEP incorporated BSA/OA hydrogels with different
amounts of oleic acid presenting in the hydrogel. The excitation wavelength was set at
532 nm, and the emission was scanned from 600 to 750 nm.
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5.4.7 The effect of the concentration of acceptor and donor
The effect of the acceptor’s amount was investigated by controlling the
composition of a series of upconversion hydrogels. The preparation of hydrogels was
followed as described above. The concentrations of BSA, oleic acid, ethanol, and sodium
hydroxide were kept constant for all hydrogels. The concentration of PdOEP was kept as
10 µM, and the concentration of DPA was varied.
Firstly, the emission spectra were taken with and without the presence of DPA
(Figure 5.6a). The excitation was set as 532 nm, which is the maximum absorbance peak
of PdOEP. The emission spectra were scanned from 600 to 750 nm, to observe the
emission of PdOEP. Without the presence of DPA, only the emission of PdOEP can be
observed at 660 nm. When 1.5 mM DPA presented in the hydrogel, the emission from
PdOEP was not observable. Comparing these spectra, when the acceptor, DPA,
presented in the hydrogel, the emission from the donor, PdOEP, was fully transferred to
the acceptor.
After then, the effect of the concentration of donor was also investigated with a
similar method. Briefly, the composition of the hydrogel was kept constant. The
concentration of DPA was kept as 1.5 mM, and the concentration of PdOEP was varied
from 0 to 30 µM. The excitation wavelength was set as 532 nm, to excite the upconversion
donor, and the emission was scanned from 600 to 750 nm, to investigate the emission
from the donor (Figure 5.6b).
With increasing concertation of PdOEP, and emission of PdOEP was not observed
until the concentration was as high as 30 µM. With 1.5 mM PDA presented in the hydrogel,
the emission energy from at least 20 µM PdOEP can be fully transferred to the acceptor.
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Figure 5.6
(a) The emission spectra of BSA/OA hydrogel with 1.5 mM (red) and 0 mM (blue) DPA,
the upconversion acceptor. The hydrogels were prepared as described above, and the
concentration of PdOEP was kept constant as 10 µM, the amount of oleic acid was kept
constant as 15%. The excitation wavelength was set as 532 nm, and the emission from
600 to 750 nm was scanned. The insert photograph is the hydrogels with only PdOEP
(left), with only DPA (right), and with both PdOEP and DPA (middle). (b) The emission
spectra of BSA/OA hydrogel with different concentrations of PdOEP, the upconversion
donor. The hydrogels were prepared as described above, and the concentration of DPA
was kept constant as 1.5 mM, the amount of oleic acid was kept constant as 15%. The
excitation wavelength was set as 532 nm, and the emission from 600 to 750 nm was
scanned.

187

5.4.8 The preparation of upconversion paper
The upconversion hydrogel was further prepared with interlocking in filter paper
fibers for potential sensing applications (Figure 5.7). Briefly, the mixture solution of BSA,
oleic acid, ethanol, sodium hydroxide, and the upconversion pair was prepared as
described above. The solution was then drop cast on a piece of regular filter paper. The
filter paper was then cut into strips.
To confirm the necessity of heating, the filter paper strips were heated or unheated
for comparison. Both heated and unheated strips were then put in water to observe any
leaking of the chromophores. After heating, there was no leaking from the upconversion
paper. The hydrogel formed around the filter paper fibers and interlocked in the filter paper.
Without heating, the solution was dried but not stable on the filter paper. After the paper
strip was put in water, the dried solution was solubilized back to solution phase. Heating
is necessary to stabilize the hydrogel and the upconversion chromophores in the filter
paper fibers.
The filter paper with upconversion hydrogel was tested to study about the success
of upconversion. A green laser with the wavelength of 532 nm was used to excite the
donor. With a 480 nm filter, the excitation light was filtered off and only the emission light
can be observed. The upconversion paper emitted blue light as the upconversion
hydrogel, with the excitation at 532 nm.
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Figure 5.7
The schematic illustration of the preparation of upconversion paper. Briefly, the mixture
solution of BSA, oleic acid, and the upconversion pair was drop cast on filter paper, which
was then cut into strips. Without the following heating step, the mixture solution was
washed off. With heating, the mixture can’t be washed off, and the dried paper emitted
blue color with the excitation of a 532 nm laser.
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5.5 Conclusions
Here we presented an easy and facile strategy to form protein/lipid hydrogel by
annealing the physical mixture of BSA and oleic acid. The oleic acid shows an important
role of keeping the hydrogel transparent, as well as improving the fluorescence intensities
of hydrophobic chromophores. While the gel was loaded with upconversion donor and
accepter, the hydrogel achieves air-tolerant upconversion. This is the first example of a
self-healing protein-lipid hydrogel, incorporated with a chromophores pair, to overcome
limitations of current upconversion systems. This is a robust, facile, and simple strategy
to prepare free-standing, moldable, biocompatible, and biodegradable hydrogels, which
contain about 65% water and are completely transparent. The excitation of the donor,
with a commercial 532 nm laser, results in an intense blue emission with a higher energy
from the accepter, which can be visualized by the naked eye.
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Chapter 6 FluoDot Nanoparticles for Peptides and Viral Particles Delivery
6.1 Introduction
Avian infectious bronchitis (IB) is an acute and highly contagious respiratory
disease of chickens. IB is caused by Avian infectious bronchitis virus (IBV). 1 There are
about 9 billion chickens in the US and 19 billion chickens in the world. Every chicken
needs IB vaccine to get protected from infection of IB, so there is a giant market for IB
vaccines. There are two types of currently available IB vaccines, live vaccines and
inactivated vaccines.2 However, live vaccines which are more efficient than inactivated
vaccines, have the risk of residual pathogenicity. Inactivated vaccines don’t confer good
immunity, when used without live vaccines. The effectiveness of currently available
attenuated vaccines and inactivated vaccines is reduced by poor cross-protection. Live
attenuated vaccine has a strong probability of spreading of vaccine virus and help
evolving variants.
IBV genome encodes four major structural proteins, known as spike (S) protein,
nucleocapsid (N) protein, membrane (M) protein and envelope (E) protein. The S protein
is post-translationally cleaved into the outer S1 and the membrane bound S2 proteins.3
S1 protein comprises major antigenic determinants that induce neutralizing antibodies
which make it a major target of vaccine design and immune therapy;4 S2 protein is
conserved and comprises epitopes inducing cross-reactive Abs and cell mediated
immune responses. N protein is largely conserved and contains epitopes which induce
cytotoxic T lymphocyte (CTL) responses and helps in protection as well as activating B
cell responses.5 In recent years materials with well-defined submicrometer structures
have attracted biomedical industry interest.6 The nanosized lipid- or polymer-based
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particles have been designed to improve drug delivery and liposomes, virosomes, viruslike particles (VLPS) or polymeric beads have been used for vaccination, protein
separation and even blood cells substitution.
Currently there are available vaccines targeting IBV, but they are not efficient,
expensive to make, and use live attenuated viruses which pose risk of infection and need
cold-storage or easily deactivated over short periods. Instead, we are using FluoDots as
nanocarriers which are not pathogenic, can present several different antigens as a
mixture or as composite carrier which is expected to be better than these currently
available ones. Either peptide or virus particle is conjugated to the abundant carboxyl
groups on the FluoDots via EDC chemistry (Scheme 6.1). the conjugate solution is further
injected to chickens and the efficiency of vaccines is evaluated. Our hypothesis is backed
by our studies with enzyme-linked immunosorbent assay (ELISA) and reverse
transcription polymerase chain reaction (RT-PCR), which have been confirmed as
analytical tools to evaluate the efficiencies of IBV vaccines.7 Our vaccines are heat-stable,
do not need cold chain or storage, and these have a better long-term stability. If
successful, our carriers can transform the vaccine delivery strategies.
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Scheme 6.1
A schematic illustration of FluoDots used for IBV vaccines carriers. Peptide or virus
particle is conjugated to the abundant carboxyl groups on the FluoDots via EDC chemistry.
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6.2 Experimental
6.2.1 Materials
FluoDots were prepared by Dr. Kumar’s lab. Peptide 1 and peptide 2 were
customized and purchased from GenScript (Piscataway, NJ). The sequence of peptide1
is SRNATGSQP{Lys(FITC)}, and the sequence of peptide 2 is IQTRTEP{Lys(FITC)}.
6.2.2 Synthesis of FluoDot-peptide conjugate
0.1 mM FluoDot24-N solution in DI water was mixed with 5 mM EDC and stirred
for 30 minutes. Then 0.5 mM peptide 1 or peptide 2 was added and stirred at room
temperature for at least four hours. The samples were purified with gel filtration using
Sephadex G-50.
6.2.3 Agarose gel electrophoresis
0.5% agarose gel was prepared. 125 mg agarose was dissolved in 25 mL trisacetate buffer (40 mM, pH 7.0) by microwaving for 1 minute. The agarose solution was
then poured and stand for 30 minutes at room temperature. Samples were prepared by
mixing 10 μL protein solution (1 mg/mL) with 10 μL of agarose loading buffer (50% v/v
glycerol solution containing 0.01% m/v bromophenol blue). 15 μL of each sample was
then loaded in each well (7.5 μg of protein/well). The agarose gel was run at 100 mV for
25 minutes with Gibco BRL Model 200 power supplier. After running, the agarose gel was
stained with 20% v/v acetic acid solution containing 0.003% m/v brilliant blue R-250, and
destained with 10% v/v acetic acid solution.
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6.3 Results and discussion
6.3.1 Synthesis of FluoDot-peptide conjugate
The synthesis and purification of FluoDot-peptide conjugates were monitored with
agarose gel electrophoresis. As FluoDot didn’t have fluorescent labeling, while peptide
was labeled with FITC, the position of fluorescence indicates the position of the peptide,
while the position of Coomassie blue after staining indicates the position of FluoDots.
After the synthesis, the agarose gel under the UV light (Scheme 6.1a) showed that in the
reaction mixture, there were two fluorescent bands, one of which matches the position of
FluoDot, while the other one’s position matches with the position of free peptide. After
staining (Figure 6.1b), the blue spots in the reaction mixtures match with the fluorescent
bands, indicating the success of conjugation of FluoDot with peptide. Before purification,
there were both FluoDot-peptide conjugate and free peptide in the reaction mixture.
The samples were then purified by gel filtration with Sephadex G-50. During the
purification, the filtrates were collected and tested by agarose gel electrophoresis. When
the gel was observed with UV light (Figure 6.1c), the first three filtrates showed one
fluorescent band which matches with the position of FluoDot. The last two filtrates showed
one fluorescent band which matches with the position of free peptide. After the gel was
stained with Coomassie blue (Figure 6.1d), the first three filtrates showed a large amount
of FluoDot, and the last three filtrates showed relatively small amount of FluoDot. The
elution order is confirmed as FluoDot-peptide conjugate, FluoDot, and peptide.

198

Figure 6.1
(a, b) Agarose gel electrophoresis of FITC labeled FluoDot (lane 1), reaction mixtures
(lane 2 and 3), and free peptide (lane 4). The gel was observed under the UV light (a)
and stained with Coomassie blue (b). (c, d) Agarose gel electrophoresis of filtrates during
gel filtration with Sephadex G-50. Seven filtrates were collected and used for agarose gel
electrophoresis (lane 1-7). The gel was observed under the UV light (c) and stained with
Coomassie blue (d).
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6.3.2 Vaccine delivery and ELISA results
With collaborations from Dr. Khan groups from the University of Connecticut, two
antigenic peptides of spike protein (S) of IBV (1 and 2) were covalently linked to the
COOH groups on the FluoDot carriers, purified, and then injected into chickens for
immunoprotection against Avian bronchitis. Four-week-old SPF white Leghorn chickens
were given intramuscularly 200μL FluoDot vaccine formulation containing 100 µg of S
peptide of IBV. Each chicken received three doses at 2 weeks intervals. The serums were
collected once before vaccination and three times 2 weeks apart after each immunization.
Chickens at ten-weeks of age were challenged intranasally with 5x104.7 EID50 IBV M41
strain per chicken. Chickens were observed for six days and euthanized six days post
challenge. Tracheal swab samples were collected at two, four, and six days post
challenge. ELISA was used to test for antibodies produced by the chickens (Figure 6.2a
and b). The results of ELISA plate coated with peptide-1 or peptide-2 analysis confirm
that the vaccine delivery was successful with FluoDot carriers, and virus shedding from
the trachea analyzed by RT-PCR confirmed less shedding after the 6th day, when
compared to the control groups (Figure 6.2c).
The groups vaccinated with nanoparticle1, nanoparticle 2 and particle control had
lower levels of tracheal shedding of IBV than the buffer-inoculated control group, at 6
days post challenge. Thus, our vaccine appears to work but requires additional
conformational work for commercialization.
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Figure 6.2
(a) The ELISA results of FluoDot-peptide 1 injected group. (b) The ELISA results of
FluoDot-peptide 2 injected group. (c) RT-PCR data of FluoDot-peptide injected group
compared to the FluoDot control group and buffer control group.
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6.4 Conclusions and future directions
Our preliminary data demonstrate that these FluoDots caused the immunity in live
chickens. ELISA results showed the formation of antibodies corresponding to FluoDots.
Post challenge viral shedding evaluation from the respiratory tracts by quantitative realtime RT-PCR indicated that after injection of FluoDots, the viral copy number is much
lower than the buffer control group by 66%. All these results showed that FluoDots could
be used as vaccine carriers for chickens. However, the experiments need to be repeated
and validated for commercialization as carriers. One advantage of using albumin as the
core of the nanocarrier is that it can be matched with the species of interest, human
albumin for human applications and bovine for the cattle, chicken albumin for chickens
etc., Albumin is also inexpensive, readily obtained in pure form without contaminants and
sustainable. Our nanocarrier is stable even after steam sterilization, which implies that it
is heat stable and can be transported/stored without the conventional cold chain,
conferring huge savings on millions of doses.
Our future work is to confirm our initial studies with chickens with FluoDots as
safe and effective IBV vaccine delivery vehicles, and precisely determine their efficiency
against a benchmark, during the first year. As prepared FluoDots will be labeled with
known antigenic peptides for testing in chickens with the established methods to confirm
our initial studies, and we will prepare a robust pathway for commercialization of our
vaccine delivery.
The first aim is to test immunogenicity of the nanoparticle-vaccine constructs.
Preliminary results from our laboratory suggest that higher doses of immunogen might be
required to obtain a strong immune response. Also adding more antigenic peptide of IBV
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will potentiate immune response. We will evaluate 5 different antigenic peptides of IBV
derived from S1, S2 and N epitopes attached to FluoDots, and blood samples from each
experimental group will be tested by ELISA and CellTiter 96 Aqueus non-radioactive cell
proliferation assay at various time intervals.
Our second aim is to test the protective efficacy against challenge with a
pathogenic infectious bronchitis virus strain. Clinical disease (morbidity and mortality),
and pre- and post-challenge serum antibody responses will be evaluated daily for 14 days
after IBV virus challenge using ELISA and Virus neutralization. Challenge virus shedding
will be assessed via oropharyngeal and cloacal swabbing to evaluate IBV gross and
microscopic lesions in tissues after challenge by quantitative real-time reverse
transcription-polymerase chain reaction (qRT-PCR). At 14 days post challenge, serum
will be collected from all surviving birds. All birds will be euthanized, and trachea, lung,
liver and spleen will be evaluated for microscopic lesions.
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